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2. Abbreviations 
 
α anti 
aa  amino acid(s) 
Amp  ampicillin 
AMPA D-2-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid 
AP Adaptor protein 
APS Ammonium-persulfate 
ARF ADP-ribosylation factor 
ATP Adenosin-5’-triphosphate 
β beta 
BBS  BES buffered saline 
BES  N,N-bis[2-hydroxyethyl]-2-aminoethanesulfonic acid 
Borax  sodium tetraborate 
bp  base pairs 
BSA Bovine serum albumine 
cAMP Cyclic Adenosin-5’-monophosphate 
CAP Cbl associated protein 
CBP Calmodulin-binding protein 
Cdc42 Cell division cycle 42 
cDNA Complementary DNA 
CFP cyan/blue fluorescent protein 
CHAPS  3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate 
CMV  cytomegalovirus 
CNS Central nervous system 
C-TAK1 CDC twenty-five associated kinase 1 
CTAP C-terminal TAP tag 
C-terminus  carboxy terminus 
CT carboxy terminus 
CXCR CXC motif receptor 
Cys cysteine-rich region 
Da  Dalton (g/mol) 
DIG  detergent-insoluble glycolipid-enriched complexes 
DIV Days in vitro 
DMEM Dulbecco’s modified Eagles medium 
DNA Deoxyribonucleic acid 
dNTPs  deoxyribonucleoside triphosphates 
Dock180 dedicator of cytokinesis 180 
dsDNA  double strand DNA 
DTT  1,4-Dithio-DL-threitol 
E Embryonic day 
E. coli  Escherichia coli 
ECFP  enhanced cyan/blue fluorescent protein 
ECL  enhanced chemoluminescence 
EDTA Ethylenediamine-tetra acetic acid 
EGF  epidermal growth factor  
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EGTA Ethylen glycol-bis(aminoethylether)-tetra acetic acid 
EMK ELKL motif kinase 
Eph Erythropoietin-producing hepatocellular 
ephrin Eph family receptor interacting protein 
EPSP  excitatory postsynaptic potential 
EtOH  ethanol 
EYFP  enhanced yellow fluorescent protein 
FAK  Focal adhesion kinase 
FBS  fetal bovine serum 
Fc Fragment crystallization; antibody fragment 
FGF fibroblast growth factor  
Fig.  figure 
FNIII  fibronectin type III 
Fyn  Fgr/Yes-related Novel gene 
G protein  GTP-binding protein 
GAP GTPase activating protein 
GDP  guanosine diphosphate 
GEF  Guanine nucleotide exchange factor 
GFP green fluorescent protein 
GIT G protein-coupled receptor kinase-interacting protein 
GluR Glutamate receptor subunit 
GPI Glycosylphosphatidylinositol 
GRASP-1 GRIP-associated protein 1 
Grb  growth-factor receptor bound 
GRIP glutamate receptor interacting protein 
GTP guanosine triphosphate 
HBSS Hank’s balanced salt solution 
HEK  human embryonic kidney 
HeLa  Henrietta Lacks 
Hepes (Hydroxyethyl)-piperanzine-ethane sulfonic acid 
het heterozygous 
hnRNP heterogeneous nuclear ribonucleoprotein 
Ig Immunoglobulin 
IP Immunoprecipitation 
JM juxtramembrane domain 
Kan  kanamycin monosulfate 
kb  kilo bases 
KD kinase domain 
KSR1 kinase suppressor of Ras1 
lacZ Gene encoding bgal 
LB Luria-Bertani 
LC-MS/MS liquid chromatography - tandem mass spectrometry 
LTD Long-term depression 
LTP Long-term potentiation 
MARK microtubule affinity regulating kinase 
mEPSCs miniature excitatory postsynaptic currents 
MLC myosin II regulatory light chain 
MR mental retardation 
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Nck Noncatalytic region of tyrosine kinase 
NGF  nerve growth factor 
NMDA N-methyl-D-aspartate 
NP-40  Nonidet P-40 
N-terminus  amino terminus 
N-WASP  neural Wiskott-Aldrich syndrome protein 
OD  optical density 
P  postnatal day 
PAGE Polyacrylamid gel electrophoresis 
PAK  P21-activated kinase 
PAP Peroxidase Anti-Peroxidase 
Par1 protease-activated receptor 1 
PBD PDZ binding (domain) 
PBS  phosphate-buffered saline 
PBST  PBS with Tween 
PCR Polymerase chain reaction 
PDGF Platelet-derived growth factor 
PDZ  PSD-95/Discs large/ZO-1 
PDZ-RGS PDZ-regulator of heterotrimeric G-protein signaling 
PFA Paraformaldehyde 
pH  potentium hydrogenii 
PICK Protein interacting with C kinase 
PIX p21-activated protein kinase (PAK)-interacting exchange factor 
PKA Protein kinase A 
PMSF  phenylmethylsulfonyl fluoride 
pre-imm pre-immunization serum 
PRK2 PKC related kinase 2 
PSD  postsynaptic density 
PSD-95 Postsynaptic density protein 95 
PTP-BL  protein tyrosine phosphatase-basophil-like 
PTPH1 protein tyrosine phosphatase H1 
Rac Ras-related C3 botulinum toxin substrate 
Ras Rat sarcoma 
RGS Regulator of G-protein signaling 
Rho  Ras homologous member 
RhoGAP  Ras-GTPase activating protein 
RhoGEF Ras guanine nucleotide exchange factor 
RNA Ribonucleic acid 
rpm Round per minute 
RT Room temperature 
SAM Sterile-a-motif 
SDF-1 Stromal cell-derived factor 1 
SDS Sodium dodecyl sulfate 
SDS-PAGE SDS- Polyacrylamid gel electrophoresis 
SFK Src family kinase 
SH Src homology 
SHD-1 Spa2 homology domain 1 
SLD synaptic localization domain 
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Src Sarcoma virus transforming gene product 
ssDNA single stranded DNA 
TAE  Tris-acetate EDTA 
TAP tandem affinity purification 
TE  Tris-EDTA 
TEMED N,N,N’,N’-Tetra-methylethylenediamine 
TEV tobacco etch virus 
TfR transferrin receptor 
TIAM1 T-cell lymphoma invasion and metastasis 1 
TM transmembrane domain 
TR Texas Red 
Tris  Tris[hydroxymethyl]aminomethane 
TX-100  Triton X-100 
U  unit(s) 
UV  ultra-violet 
WB Western blot 
wt  wild type 
Yes Yamaguchi sarcoma viral 
YFP yellow fluorescent protein 
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3. Summary 
 
Synapses form when highly motile dendritic filopodia establish axonal contacts. 
When a synaptic contact is stabilized, it gives rise to the formation of a dendritic 
spine, which has recently been shown to involve a number of molecules that mostly 
regulate the actin cytoskeleton. Thus, it is not surprising that Eph receptor tyrosine 
kinases, as known regulators of signaling pathways involved in actin cytoskeleton 
remodeling, have been shown to be required for spine development and maintenance. 
The main characteristic of interactions of the Eph receptor with its membrane 
associated ephrin ligand is that they can propagate bidirectional signals. Both forward 
(downstream of Eph receptor) and reverse (downstream of ephrin ligand) signaling 
have been shown to play a role in mature synapses, where spine morphology changes 
are associated with synaptic plasticity. Thus, ephrinB reverse signaling might be as 
important for dendritic spine development as signaling pathways downstream of Eph 
receptors. Intrigued by this idea, we hypothesized that some of the spine morphology 
changes during plasticity might be regulated exclusively by ephrin reverse signaling 
pathways. Analyzing spine formation in cultures of dissociated hippocampal neurons, 
we demonstrated that stimulation of hippocampal neurons with EphB receptor bodies 
leads to increased spine maturation. Expression of a truncated form of ephrinB ligand, 
which is still able to activate EphB receptor but is unable to transduce intracellular 
signals, impairs spine morphology. To find new players of reverse signaling that are 
important in directing ephrin-mediated spine morphology, we performed a proteomic 
analysis of the phosphotyrosine dependent ephrin interactor Grb4 (Nck-2, Nck beta). 
We identified the signaling adaptor G protein-coupled receptor kinase-interacting 
protein (GIT)1 (Cat1) as well as the exchange factor for Rac βPIX (β-p21-activated 
protein kinase (PAK)-interacting exchange factor), also called RhoGEF7 or Cool-1, as 
novel Grb4 binding partners, which have both previously been shown to be required 
for spine formation. We show that Grb4 binds and recruits GIT1 to synapses 
downstream of activated ephrinB ligand. Interactions of Grb4 with ephrin or GIT1 are 
necessary for proper spine morphogenesis and synapse formation. We therefore 
provide evidence for an important role of ephrinB reverse signaling in spine formation 
and describe the ephrinB reverse signaling pathway involved in this process. 
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An important motif in the cytoplasmic tail of ephrinB ligand is a carboxy-terminal 
PDZ binding domain, which binds some multi-PDZ-domain-containing proteins. 
Thus, the current model for ephrinB reverse signaling implies a switch from an early 
and quick phosphotyrosine-dependent signaling to a more delayed and sustained PDZ 
domain-dependent signaling. One of these PDZ adaptors, GRIP1 (glutamate receptor 
interacting protein 1), is a 7 PDZ-domain containing protein that was shown to be 
specifically recruited into rafts through association with the cytoplasmic domain of 
ephrinB. In the work presented, we have used a proteomic analysis of GRIP1-binding 
proteins in neuroblastoma cells and in vivo in transgenic mice to identify protein 
complexes that are involved in PDZ-dependent signaling downstream of ephrinB 
ligands. Our results show GRIP1 binding partners with a remarkable range of cellular 
activities. Interaction with one binding partner, 14-3-3 proteins, was validated in vivo 
in the adult mouse brain, and more interestingly, we were able to show that this 
interaction occurs exclusively in rafts. Identification of a 14-3-3 binding site in GRIP1 
and the formation of a triple complex of ephrinB ligand, GRIP1 and 14-3-3 in rafts 
strongly implicates that this new interaction has an important functional relevance in 
ephrinB reverse signaling. 
4. Introduction 
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4. Introduction 
 
The brain serves as a center for cognitive function and neurons within the brain relay 
and store information about our surroundings and experiences. Modulation of 
neuronal circuitry allows us to process that information and respond appropriately. 
Proper development of neurons is therefore vital to the mental health of an individual, 
and perturbations in their signaling or morphology are likely to result in cognitive 
impairment. The development of a neuron requires a series of steps that begins with 
migration from its birthplace and initiation of process outgrowth, and ultimately leads 
to differentiation and the formation of connections that allow it to communicate with 
appropriate targets. Such processes require that cells communicate with each other 
and their environment. Information from outside of the cell is received via surface 
receptors that recognize specific stimuli and transduce signals into the interior of the 
cell in order to evoke the proper responses. Intracellular signal transduction is, 
however, not just a linear transmission of information. It rather involves complex 
networks of molecular interactions that require specific mechanisms to regulate 
important steps in different aspects of neuronal development including neurite 
outgrowth, differentiation, axon pathfinding and dendritic spine formation and 
maintenance. 
 
4.1 Actin cytoskeleton and dendritic spine formation 
 
The construction of neuronal circuits in the developing brain requires the correct 
assembly of trillions of synaptic connections. How, given the enormous numbers of 
axon and dendrites seeking contact in the growing neuropil, do the right partners 
manage to find one another? The challenge is met by a combination of genetically 
fixed routines that produce a “rough draft” of the final circuitry, followed by a process 
of experience-driven plasticity that refines the detailed pattern of connectivity during 
a critical period of juvenile learning (Berardi et al. 2004; Hensch 2004). Dendritic 
spines, small protrusions scattered along the dendrites of brain neurons, play a crucial 
part in this process (Figure 1). During development, immature dendrites first produce 
motile filopodia that search the developing neuropil for active presynaptic partners 
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with which to form synaptic contacts (Ziv and Smith 1996; Jontes and Smith 2000; 
Dunaevsky and Mason 2003; Yuste and Bonhoeffer 2004). These filopodia are later 
replaced by more stable mature spines, which typically comprise an expanded head 
joined to the dendrite shaft by a narrow neck (Figure 2). In this morphologically 
mature state, plasticity is restricted to motile ruffling of the spine head (Fischer et al. 
1998; Dunaevsky et al. 1999; Roelandse et al. 2003). The motility of both filopodia 
and spines depends on the turnover of actin filaments in the spine cytoskeleton (Matus 
et al. 2000; Star et al. 2002; Portera-Cailliau et al. 2003), suggesting that the transition 
from filopodia to mature spines involves the down-regulation of actin dynamics. 
 
Figure 1. Three-dimensional reconstructed electron microscopy picture of a dendrite, 
two spines and an associated axon. (a) A single electron microscope section of a dendrite 
and two spines that are associated with a passing axon. The axon makes a mature synapse 
with one of the spines. (b) Reconstructed dendrite (shown at a different angle), which shows 
the types of connections that are formed in hippocampal cultures (modified from Luo 2000). 
 
4.1.1 Spine formation 
 
How do spines develop and what regulates spine formation? There are several views 
on the origin of dendritic spines. In most cells, dendritic spines are more prominent in 
older cells while dendritic filopodia are more prominent on younger dendrites (Dailey 
and Smith 1996). Spines can be converted from an existing shaft synapse or formed 
de novo from a filopodium, which emerges from the dendrite, forms a synapse with 
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the presynaptic terminal and then collapses to become a short, 1-2 μm, “mature” spine 
(Harris and Kater 1994; Dailey and Smith 1996. The molecular mechanisms that lead 
to the formation of a mature, functional spine might be different for the two cases, as 
might the involvement of adhesion molecules and postsynaptic density protein 95 
(PSD-95) (El-Husseini, 2000 #43; Abe et al. 2004). An intermediate process has been 
proposed, in which a filopodium searches for a presynaptic partner, makes contact and 
pulls the axon close to the dendritic shaft, from which it later extrudes a spine. The 
mechanisms for producing spines in mature neurons might differ from that in 
developing neurons (Dailey and Smith 1996). Therefore, the different models may not 
be mutually exclusive and both extrinsic and intrinsic factors could potentially 
regulate the formation of dendritic spines. Indeed, cell-specific differences in 
regulation of formation of dendritic spines have been postulated (Yuste and 
Bonhoeffer 2004). 
 
 
Figure 2. Morphology of dendritic spines. (a) A pyramidal neuron in hippocampal slice 
culture transfected with green fluorescent protein (GFP) imaged with two-photon microscopy. 
Dendrites are covered by small protrusions: the dendritic spines. (b) High magnification 
image of a hippocampal dendrite demonstrating the diversity in the morphology of dendritic 
spines. Most dendritic spines, however, have a narrow neck and an enlarged head. (c) A 
schematic representation of morphological classifications of dendritic spines (modified from 
Lippman and Dunaevsky 2005). 
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4.1.1.1 Filopodia as spine precursors 
 
As synapses form, the number of filopodia declines and the number of stable spine-
like structures increases, suggesting that filopodia are the precursors of dendritic 
spines. In cultures of dissociated hippocampal neurons, Ziv and Smith (1996) first 
succeeded in visualizing in real-time the formation of contacts between dendritic 
filopodia and nearby functional presynaptic terminals using two different fluorescent 
dyes (Ziv and Smith 1996). Based on these observations, a sequence of events was 
proposed in which filopodia encounter axons, engage in synaptic contact and undergo 
a “filopodia to spine” transformation, which involves a decrease in motility, 
substantial shortening and development of a mature-shaped spine containing a head 
and a neck (Figure 3a). More recently, in vivo data has supported the hypothesis that 
synapse formation triggers the transformation of filopodial structures into spines 
(Dailey and Smith 1996; Maletic-Savatic et al. 1999; Marrs et al. 2001; Okabe et al. 
2001; Trachtenberg et al. 2002), suggesting that the function of the highly motile 
filopodium is to probe the space around the dendrite for an appropriate contact site on 
an axon. Interestingly, the release of the neurotransmitter glutamate promotes 
filopodial extension (Portera-Cailliau et al. 2003). Thus, it appears that this 
mechanism may guide filopodia to sites of presynaptic vesicle release. 
 
4.1.1.2 Spine formation from the dendritic shaft 
 
Spines have also been proposed to arise from synapses located on the dendritic shaft 
(Miller and Peters 1981), which originates from the observation that the majority of 
synapses in young pyramidal neurons are located on the dendritic shaft rather than on 
filopodia (Harris and Kater 1994). As neuronal networks mature, the number of spine 
synapses increases and the number of shaft synapses decreases suggesting that axonal 
filopodia (and not dendritic filopodia) may be involved in finding an appropriate 
region for synaptic contact on the dendritic shaft (Figure 3b). However, movement of 
axonal filopodia in pyramidal neurons remains to be examined, whereas electron 
microscopy images have indeed captured axonal filopodia in synaptic contact with the 
dendritic shaft (Fiala et al. 1998) and, moreover, live imaging of pyramidal neurons in 
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hippocampal slices have documented the emergence of mature spines from shaft 
synapses (Dailey and Smith 1996; Marrs et al. 2001). Therefore, it seems that spines 
can both emerge from the dendritic shaft and derive from filopodial precursors. A 
combination of these two models has also been proposed based on three-dimensional 
reconstruction from electron micrographs (Fiala et al. 1998) and live imaging 
experiments (Marrs et al. 2001) showing filopodia, which have established a synaptic 
contact, retract, thereby pulling the synapse towards the dendritic shaft and 
transforming it into a shaft synapse that later gives rise to a dendritic spine. Together, 
these experiments suggest that dendritic spine morphogenesis in hippocampal and 
cortical pyramidal neurons can occur through a combination of mechanisms. 
However, it is possible that a particular mechanism prevails in vivo. 
 
 
 
Figure 3. Three models of dendritic genesis. In model 1 (a), a dendritic filopodium captures 
an axonal terminal and becomes a spine. In model 2 (b), the terminal actually induces the 
formation of the spine. Finally, in model 3 (c), spines emerge independently of the axonal 
terminal (modified from Lippman and Dunaevsky 2005). 
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4.1.1.3 Spine formation without synaptic contact 
 
Although in both models above, the formation of synaptic contacts induces the 
development of dendritic spines, it seems that the presynaptic terminal is not 
absolutely required for the formation of all spines (Figure 3c). It has been shown that 
spine-shaped protrusions in cerebellar Purkinje neurons form through intrinsic 
mechanisms in the absence of axonal contact (Sotelo et al. 1990; Takacs et al. 1997). 
Indeed, morphologically normal dendritic spines in Purkinje cells form before the 
establishment of synaptic contact with the presynaptic parallel fibers, as seen in mice 
with mutations causing the absence of parallel fibers.  
In summary, the experimental evidence suggests that dendritic spines may form 
through different mechanism in different types of neurons, perhaps due to different 
molecular compositions (Carlin et al. 1980; Mundel et al. 1997; Rao et al. 1998; 
Sekerkova et al. 2003). 
 
4.1.2 Spine motility 
 
Live imaging of dendritic spines has revealed that dendritic protrusions are highly 
dynamic (Bonhoeffer and Yuste 2002). More mature dendritic spines with heads 
exhibit a more subtle type of motility than dendritic filopodia on young neurons, 
which show protrusive motility (Fischer et al. 1998). Local spine motility, or 
“morphing”, which might be relevant to the role of spines in memory formation, is 
powered by actin filament polymerization (Fischer et al. 1998; Dunaevsky et al. 1999) 
and might even still occur in the presence of a functional contact (Dunaevsky et al. 
2001; Deng and Dunaevsky 2005). The functional significance of spine morphing is 
not known, but the authors of a recent study proposed that it might be involved in the 
diffusion of molecules through the plasma membrane into the spine (Richards et al. 
2004). In this scenario, spine motility may have roles additional to the formation of 
initial cell-cell contacts. Such a mechanism might also be important for the fast 
delivery of receptors into the synapse, a process that is likely to be accelerated during 
the acquisition of memory. In addition, spine motility after synapse formation could 
serve to alter the signaling at the synapse, since alterations in spine shape have been 
shown to change calcium dynamics (Majewska et al. 2000). This may in turn lead to 
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activation of alternative pathways or potentiation of certain synapses over others and 
might therefore provide a mechanism for activity-dependent learning. 
 
4.1.3 Spine shape and function 
 
It has been reported that the size of miniature excitatory postsynaptic currents 
(mEPSCs) recorded at the soma after glutamate activation of single spines is 
positively correlated with the size of the spine head, that is, large spines produce large 
synaptic responses (Matsuzaki et al. 2001). It is likely that spines with larger heads 
accumulate more glutamate receptors and more of their interacting proteins, thereby 
producing larger somatic responses after synaptic activation. However, in other 
studies no difference or the opposite effect was seen in mEPSC properties (Murphy et 
al. 1998; El-Husseini et al. 2000; Pilpel and Segal 2004). 
 
4.1.4 Spines and memory 
 
Dendritic spines are the principal postsynaptic targets for excitatory synapses (Harris 
1999) and changes in their morphology are implicated in synaptic plasticity and long-
term memory (Segal and Andersen 2000). Synaptic plasticity is a term used to 
describe how synapses change in response to stimuli. The perforant path, an important 
input to the hippocampus, shows activity-dependent plasticity, which is called long-
term potentiation (LTP) (Bliss and Gardner-Medwin 1973). LTP is induced by a 
strong presynaptic stimulus and results in an increase in synaptic efficacy that can last 
up to hours in vitro and days or weeks in vivo. Activity-dependent synaptic plasticity 
often requires N-methyl-D-aspartate (NMDA)-type glutamate receptors, which are 
coincidence detectors requiring both presynaptic activity (glutamate release) and 
postsynaptic activity (depolarization) to control Ca2+ entry into the postsynaptic side 
of excitatory synapses. Ca2+ influx by NMDA receptors and associated signaling 
pathways orchestrate synapse formation and plasticity (Helmchen 2002). If learning 
and memory indeed correlate with persistent changes in spine morphology, some 
important criteria should be met. These spine morphology changes should be 
temporally associated with changes in memory and, in addition, the magnitude of 
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changes in spines has to correlate with changes in cellular behavior. Moreover, 
changes in spine morphology after acquisition of a memory should be blocked or 
enhanced by drugs that block or enhance memory formation, respectively . If changes 
in spine cause changes in memory, it will be interesting to address whether the 
formation of a “memory” is directly inducible by generating changes in spines. 
Finally, depotentiation or long-term depression (LTD) is a weakening of a synapse 
that lasts from hours to days and may result from persistent weak synaptic patterned 
stimulation (e.g. a 1-Hz stimulus). To establish a causative connection between spines 
and the formation and/or maintenance of memory, LTD, which represents an in vitro 
model for erasure of memory, should therefore be associated with a reversal of the 
spine changes. 
 
4.1.4.1 Changes in spines after a learning experience 
 
At present, no evidence for the involvement of spine formation in memory meets any 
of the above mentioned criteria and the main question is still what type of spine 
changes take place after a learning experience. The heterogeneity of the observed 
changes in spine morphology may be due to a number of reasons, such as the use of 
different experimental conditions, timescales or type of spines. Because of its high 
resolution, the three-dimensional reconstruction of spines after learning experience 
using electron microscopy should be the ultimate approach for measuring changes in 
individual spines and dendrites. However, as this is the most labour-intensive method, 
it is not used extensively. In summary, there has not been a consistent picture yet of 
the changes in spine dimensions after memory formation and some of the changes 
observed are probably transient and diminish with different time courses.  
One morphological change that has been reported by five independent groups in the 
past year, although to quite a heterogeneous extent, involves a rapid expansion of 
spine heads after tetanic stimulation in hippocampal slices or cultures. Matsuzaki and 
colleagues found a threefold increase in spine volume within 2-4 minutes after 
induction of LTP, which fell to a ~20-30% increase in spine volume after 20-40 
minutes (Matsuzaki et al. 2004). A similar change, albeit much smaller and slower 
(18% increase in the spine/dendrite ratio) was reported by Otmakhov et al. after the 
induction of LTP by bath application of forskolin (Otmakhov et al. 2004). However, 
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another study, reported that these changes occurred in only ~6% of the imaged spines 
(Lang et al. 2004), which is unlikely to underlie the twofold increase in field EPSP 
that was recorded in the same tissue slices.  
Recent evidence has confirmed that stimulation patterns associated with LTP increase 
the spine volume up to twofold and, moreover, using fluorescence resonance energy 
transfer (FRET) this has been shown to be associated with increases in levels of 
polymerized actin in spines (Okamoto et al. 2004). These effects are mediated by 
NMDA receptor activation, which also leads to an increase in the levels of both actin 
and actin binding proteins in the spine cytoskeleton (Furuyashiki et al. 2002; 
Ackermann and Matus 2003; Okamoto et al. 2004). Interestingly, drugs that inhibit 
actin dynamics selectively block LTP (Kim and Lisman 1999; Krucker et al. 2000; 
Chen et al. 2002) and slightly enhance LTD (Chen et al. 2002). And indeed, they also 
found that LTD was associated with spine shrinkage and an increase in the relative 
amount of G-actin in the spine head (Chen et al. 2002; Okamoto et al. 2004). Taken 
together, these data strongly suggest that in mature dendritic spines actin filament 
dynamics are closely coupled to LTP and LTD. Finally, Zhou reported a slow (20-60 
minutes) and small (16-33%) increase in the diameter of the spine heads after high 
frequency stimulation (Zhou et al. 2004). This study also showed for the first time 
symmetry between changes in spines and synaptic responses, in that spine heads 
shrunk after the induction of LTD and were enlarged after the formation of LTP, 
which is consistent with the expansion of the postsynaptic density (Fifkova and 
Anderson 1981; Desmond and Levy 1986), and could underlie an enhanced synaptic 
response and an increase in the amplitude of mEPSCs (Matsuzaki et al. 2004). 
Another morphological change in dendritic spines that can be seen is the formation of 
new spines, which was originally observed in cultured slices of the hippocampus and 
involved the accelerated formation of filopodia in response to local stimulation 
(Maletic-Savatic et al. 1999). A similar observation was made using a patterned LTP-
producing stimulus in cultured hippocampal slices (Engert and Bonhoeffer 1999) and 
was reproduced and extended in dissociated hippocampal cultures (Goldin et al. 2001) 
and in hippocampal slices (Jourdain et al. 2003). Similar to the expansion of spine 
heads, it is not clear whether the formation of new spines (1-6 spines per 100 μm 
(Engert and Bonhoeffer 1999; Jourdain et al. 2003)) can explain the changes observed 
in the electrophysiological responses, which normally increase up to 50-100% above 
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control levels. An explanation for this may be that most new spines are non-functional 
and therefore new spines constitute a greater proportion of active spines. 
 
4.1.4.2 Spines and long-term depression 
 
What happens when LTP and memories are erased (or depontentiated) or when the 
synapse is depressed by the induction of LTD? As mentioned above, in contrast to the 
changes observed upon induction of LTP, there is a shift to a lower F-actin/G-actin 
ratio in the spine head in response to LTD perhaps leading to the observed spine 
shrinkage (Okamoto et al. 2004). Zhou found a 25-40% shrinkage in the diameter of 
spine heads, which persisted for an hour after LTD induction (Zhou et al. 2004). 
Moreover, more spines disappear in a period of 6 hours after the induction of LTD (2-
3 spines per 100 μm of dendrite) than would be expected to disappear spontaneously 
(Nagerl et al. 2004). 
Taken together, these studies show that dendritic spines shrink and/or disappear when 
LTD is induced, which is consistent with the hypothesis that LTP or LTD are two 
directly opposed mechanisms that after formation lead to larger and more or smaller 
and fewer spines, respectively. 
 
4.1.4.3 Spine persistency 
 
How persistent are the changes in spine morphology and number after a stimulus has 
occurred? Two studies demonstrated that there are changes in spine density in rat 
brains 9 hours but not 24 hours after training on a water maize (Eyre et al. 2003) and 6 
hours but not 72 hours after passive avoidance training (O'Malley et al. 2000), which 
would indicate that morphological changes are transient. However, using two-photon 
microscopy in the intact brain, two recent studies came to the opposite conclusion 
regarding this issue. One study showed that in the mouse barrel cortex, about 50% of 
spines were transient, with a half-life of days (Trachtenberg et al. 2002). The other 
study showed that, in the mouse visual cortex, most spines (96%) were stable over 
months (Grutzendler et al. 2002), which might, though, also represent one extreme of 
the normal distribution of spine stability, whereas the first study represents a value 
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that is below the mean of spine stability. This discrepancy might on the other hand be 
explained by the fact that the studies use different cell types and different 
methodologies as well as by different activity patterns in the visual and somatosensory 
cortices.  
Regardless of the discrepancy between the observations of different studies, the issue 
of spine persistency is important where memory is concerned. If spines are transient 
by nature, then their function cannot be related to long-time memory. Nevertheless, as 
mentioned above, some neurons might be more plastic than others and, for example, 
spine density on CA1 neurons can vary by 30% across the oestrus cycle, which does 
not necessarily mean that 30% of memories are lost during that time (Woolley and 
McEwen 1993). 
 
4.1.5 Cellular processes regulated by spine signaling 
 
Together with the regulation of AMPA receptors (Malinow and Malenka 2002) and 
local protein synthesis (Steward and Schuman 2003; Klann and Dever 2004), changes 
in the spine cytoskeleton have a crucial role in synaptic plasticity (Matus et al. 2000; 
Yuste and Bonhoeffer 2001; Carlisle and Kennedy 2005). Several mutations in human 
proteins that regulate the actin cytoskeleton cause mental retardation (Ramakers 
2002). Several studies have shown that synaptic stimulation alters the spine 
cytoskeleton (Lin et al. 2005), and that altering the actin dynamics interferes with 
synaptic plasticity (Fukazawa et al. 2003; Rabenstein et al. 2005). Actin dynamics in 
the spine are influenced by Ca2+ flux through activated NMDA receptors (Fukazawa 
et al. 2003; Tolias et al. 2005) and by signaling through Eph receptors, which activate 
the Rho GTPase Rac1 (Henkemeyer et al. 2003; Penzes et al. 2003). Rac1 belongs to 
the Rho family of small GTPases, which transduces signals from extracellular stimuli 
to the actin cytoskeleton and to the nucleus. Recent evidence implicated Rho GTPases 
in the regulation of neuronal morphogenesis, including migration, polarity, axon 
growth and guidance, dendrite formation and plasticity, and synapse formation (Luo 
2000). Rho GTPases constitute a subfamily of the Ras superfamily of small GTPases 
( 200 amino acids long). The best-studied Rho GTPases are RhoA (Ras homologous 
member A), Rac1 (Ras-related C3 botulinum toxin substrate 1) and Cdc42 (cell 
division cycle 42). Rho GTPases act as molecular switches and exist in two states: a 
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GDP-bound inactive state and a GTP-bound active state. Two classes of protein 
facilitate the switch between these two states. Guanine nucleotide exchange factors 
(GEFs) facilitate the exchange of GDP for GTP, thereby activating Rho GTPases. 
When bound to GTP, activated Rho GTPases can bind to various effectors and elicit 
different biological activities. By contrast, GTPase activating proteins (GAPs) 
increase the endogenous GTPase activity of Rho GTPases, thereby helping to switch 
them off (Luo 2000) (Figure 4). 
 
 
 
Figure 4. Rho GTPases as molecular switches. Upstream signals transduce signals to Rho 
GTPases through regulation of the activities of guanine nucleotide exchange factors (GEFs) 
or GTPase-activating proteins (GAPs), which facilitate switching on or off Rho GTPases. In 
their GTP-bound state, Rho GTPases bind to and activate their effectors to transduce the 
signal downstream. 
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4.1.5.1 Regulation of the actin cytoskeleton in spines by Rac 
 
During the development of synapses, the activation of NMDA receptors and EphB 
receptors influences spine morphology by regulating actin remodeling (Tolias et al. 
2005). In mature spines, the activation of NMDA receptors increases actin 
polymerization (Fukazawa et al. 2003), and activation of EphB receptors is necessary 
to maintain spine morphology (see below). Regulation of the cytoskeleton by NMDA 
receptors is mediated by TIAM1 (T-cell lymphoma invasion and metastasis 1), a Rac-
specific GEF that is expressed at high levels in the developing and adult brain (Tolias 
et al. 2005). Knockdown of TIAM1, or expression of a dominant-negative TIAM1, in 
hippocampal neurons disrupts the effects of NMDA receptor activation on the spine 
cytoskeleton. TIAM1 is present in dendrites and spines where NMDA receptor 
stimulation could lead to activation of its RacGEF activity. An entirely separate 
mechanism for activating Rac, through EphB receptors, has also a prominent role in 
controlling the actin cytoskeleton, but will be discussed in greater detail in chapter 
4.2. Other cytosolic proteins have been shown to regulate Rac activity in spines 
modulating spine morphology. One of these proteins, G-protein-coupled receptor 
kinase-interacting protein (GIT)1, has been shown to be a key regulator of spine 
morphology and synapse formation (Zhang, H. et al. 2003). Disrupting the synaptic 
localization of GIT1 by a dominant-negative mutant resulted in numerous dendritic 
protrusions and a significant decrease in the number of synapses and normal 
mushroom-shaped spines. The phenotype resulted from mislocalized GIT1 and its 
binding partner p21-activated protein kinase (PAK)-interacting exchange factor (PIX), 
an exchange factor for Rac, which is mutated in patients with nonsyndromic mental 
retardation. In another recent study, Zhang and colleagues were able to rescue the 
spine defects of GIT1 knockdown with activated PAK (p21-activated protein kinase) 
or myosin II regulatory light chain (MLC), which suggests that GIT1 functions 
through PAK and MLC (Zhang, H. et al. 2005). This points to a signaling complex 
consisting of GIT1, PIX, Rac and PAK that functions in regulating dendritic spine and 
synapse formation through modulating MLC activity. The molecule(s) that recruit this 
signaling complex to the synaptic membrane are currently unknown.  
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4.2 Eph receptors and their ephrin ligands 
 
Eph receptors and their membrane-bound ligands, the ephrins, are unique in the 
receptor tyrosine kinase family because their signaling is bidirectional, through both 
the receptor and the ligand (Kullander and Klein 2002). The Eph/ephrin system is 
mainly engaged in cell-to-cell communication between adjacent cells. To date, a 
variety of biological functions have been demonstrated for Eph receptors and ephrins, 
including vascular development, tissue-border formation, cell migration, axon 
guidance and synaptic plasticity (Palmer and Klein 2003). Roles of Ephs and ephrins 
in the biology of stem cells, immune function, blood clotting and tumor formation are 
also beginning to be characterized (Zou et al. 1999; Conover et al. 2000; Wohlfahrt et 
al. 2004; Clevers and Batlle 2006). The influence of this peculiar bi-directional 
signaling on cell behavior is, in most cases, repellent to cellular processes such as the 
neuronal growth cone (Zimmer et al. 2003). However, some examples of adhesive 
responses mediated by Eph and ephrin have also been described (Holmberg et al. 
2000). How the choice between repulsion and adhesion is regulated in vivo at the 
molecular level is so far unknown, although endocytosis of Eph and ephrin complexes 
have been postulated to play a role in this decision (Zimmer et al. 2003). In molecular 
terms, most of the signaling pathways downstream of Ephs and ephrins converge to 
remodel the cytoskeleton rather than having a regulatory effect on transactivation of 
gene expression (Murai et al. 2003; Noren and Pasquale 2004). 
 
4.2.1 The Eph class of receptor tyrosine kinases: forward signaling 
 
Eph receptors, which constitute the largest receptor tyrosine kinase family, are 
subdivided based on sequence similarity into two classes, EphA and EphB receptors. 
These two groups also correspond to the binding preference for the different ephrins. 
Promiscuous receptor-ligand interaction within each A or B class has been observed 
with two exceptions, ephrinA5, able to bind at high concentrations to EphB2 
(Himanen et al. 2004) and EphA4, which binds to all ephrinBs (Pasquale 2005). In 
vertebrates there are ten EphA and six EphB receptors, EphA1 – EphA10 and EphB1 
– EphB6 (Murai and Pasquale 2003; Pasquale 2004), which all share a common 
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structure. The extracellular part of Eph receptors includes the N-terminal ephrin-
binding domain, a cysteine-rich region (containing an epidermal growth factor (EGF)-
like motif) and two fibronectin type-III repeats (FNIII). The intracellular part includes 
a juxtamembrane segment that includes two conserved tyrosine residues, a classical 
protein tyrosine kinase domain, a sterile-α-motif (SAM) implicated in mediating 
protein-protein interaction via the formation of homo and heterotypic oligomers, and a 
PDZ (PSD 95/Disc large/ZO-1)-binding motif. The extracellular and intracellular 
parts are connected by a single membrane-spanning segment (Figure 5). The PDZ 
binding motif mediates protein-protein interactions by binding to PDZ domain-
containing proteins in a sequence-specific fashion.  
 
 
 
Figure 5. Eph receptors. The N-terminal globular ligand binding domain (Glob) is followed 
by a cysteine-rich region (Cys) and two fibronectin type III repeats (FNIII), which contain a 
dimerization motif. Phosphorylated tyrosine residues (P) provide docking sites for SH2 
domain-containing signaling proteins. Sterile--motif (SAM) domains form homodimers and 
may regulate receptor dimerization. Signaling proteins containing PDZ domains dock to a 
PDZ-binding domain (PBD) in the carboxy terminus of Eph receptors. Transmembrane 
domain (TM), juxtamembrane region (JM), kinase domain (KD). 
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4.2.1.1 Eph-ephrin clusters 
 
Another unique feature of this receptor-ligand system is that their functional signaling 
requires the formation of higher-order clusters (Stein et al. 1998). Upon formation of a 
monovalent interaction between an Eph receptor and an ephrin on juxtaposed cell 
surfaces with subsequent dimerization of two Eph-ephrin dimers into a tetramer, these 
complexes can progressively aggregate into larger clusters, the size of which might 
depend on the densities of Eph receptors and ephrins on the cell surface (Himanen and 
Nikolov 2003; Smith et al. 2004). Several weak ephrin-ephrin and receptor-receptor 
interactions, which include regions in the extracellular and juxtamembrane domain of 
ephrins, and in the ephrin-binding domain, cysteine-rich region and cytoplasmic SAM 
domain of Eph receptors, could promote the association of the complexes into an 
interconnected network (Himanen and Nikolov 2003). PDZ-domain proteins bound to 
Ephs and B-class ephrins might contribute to stabilize the clusters and lateral 
association of Eph receptors may help to expand these receptor signaling clusters 
beyond the region of cell-cell contact (Wimmer-Kleikamp et al. 2004).  
 
4.2.1.2 Activation and signaling 
 
Ligand engagement of the receptor dimer induces trans-activation of the receptor and 
subsequent autophosphorylation of several juxtamembrane tyrosine residues in the 
partner receptor (transphosphorylation), which is required for full activation of the 
protein tyrosine kinase domain of the receptor (Binns et al. 2000; Zisch et al. 2000; 
Kullander et al. 2001). The kinase domain of one receptor from each class (EphA10 
and EphB6) lacks residues that are essential for catalytic activity. Upon activation by 
ephrins, Eph receptors become heavily phosphorylated on tyrosine residues through 
Src-family kinases (SFKs) that are often associated with the receptor (Kalo and 
Pasquale 1999; Knoll and Drescher 2004). Upon phosphorylation of juxtamembrane 
tyrosine residues, the juxtamembrane domain is then released from the interaction 
with the kinase domain allowing the kinase domain to convert into its active state. The 
functional relevance of this activation in large signaling clusters has been recently 
revealed and shown to be important for a number of axon guidance decisions (Egea et 
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al. 2005). This phosphorylation via SFKs or transphosphorylation enables 
phosphotyrosine-binding proteins containing Src-homology-2 (SH2) domains to bind 
to the phosphorylated juxtamembrane domain (Kalo and Pasquale 1999; Kullander 
and Klein 2002; Murai et al. 2003; Prevost et al. 2003; Brantley-Sieders et al. 2004). 
Those adaptor proteins are a growing class of proteins that often lack intrinsic 
enzymatic activity and which, however, play important roles in the formation of 
protein complexes to connect signaling molecules to upstream and downstream 
signaling events. Although Eph receptors and ephrins are often co-expressed in the 
same cells and have been localized to lipid rafts (Wu et al. 1997; Bruckner et al. 1999; 
Huai and Drescher 2001; Gauthier and Robbins 2003), it is not known whether they 
mix and are free to interact laterally or if they are segregated in different subdomains 
of the plasma membrane. Interestingly, targeting of EphA receptor into ephrin-A-
enriched membrane domains has been shown to also lead to cis-interactions, which 
consequently attenuates trans-activated signaling (Marquardt et al. 2005). 
 
4.2.2 Ephrin ligands: reverse signaling 
 
The ligands are also divided into two subclasses: the A-subclass (ephrinA1-
ephrinA5), which are tethered to the cell membrane by a glycosylphosphatidylinositol 
(GPI) anchor, and the B-subclass (ephrinB1-ephrinB3), which have a transmembrane 
domain that is followed by a short cytoplasmic region (Figure 6). The ligands do not 
have intrinsic enzymatic activity. 
 
 
  4. Introduction 
  28 
4.2.2.1 Signaling through transmembrane ligands 
 
The cytoplasmic domain of ephrinB ligands contains five conserved tyrosine residues. 
Three of these tyrosines (residues 312, 317 and 332) have been identified as the main 
in vivo tyrosine phosphorylation sites of activated avian ephrinB1 from neuronal 
tissue (Kalo and Pasquale 1999). These residues become phosphorylated following 
stimulation with clustered soluble ectodomain of Eph receptors (Palmer et al. 2002), 
with the fibroblast growth factor (FGF), presumably by the co-expressed FGF 
receptor (Chong et al. 2000), and by stimulation of the endogenous PDGF (platelet 
derived growth factor) receptor (Bruckner et al. 1997). Phosphorylation of ephrinB 
cytoplasmic domain is positively regulated by SFKs, which are rapidly recruited to 
ephrinB-containing membrane clusters by EphB2 receptor stimulation (Palmer et al. 
2002) (Figure 7a). However, phosphorylation of ephrinB ligands is a transient event 
and, with delayed kinetics, the PDZ-domain containing protein-tyrosine phosphatase 
PTP-BL (protein tyrosine phosphatase-basophil-like) is recruited to these ephrinB 
membrane clusters through interaction with the PBD in ephrinB. PTPBL can thereby 
act as a negative regulator of ephrinB phosphorylation and Src activity. Thus, this 
mechanism may induce a switch from phosphotyrosine-dependent signaling to PDZ-
domain-dependent-signaling (Palmer et al. 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
_____________________________________________________________________ 
Figure 6. Ephrin ligands. The two ephrin classes differ in their type of membrane 
attachment, that is, GPI-anchored (ephrinA) versus transmembrane region (ephrinB). EphrinA 
ligands: N-terminal ephrin domain (extracell), glycosylphosphatidylinositol (GPI) anchor. 
EphrinB ligands: N-terminal ephrin domain (extracell), cytoplasmic domain (Cyto), PDZ-
binding motif (PBD), tyrosine phosphorylation sites (P).  
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4.2.2.1.1 Phosphorylation-dependent signaling by ephrinB via Grb4 
 
The SH2-SH3 domain adaptor protein Grb4 (growth-factor-receptor-bound protein 4) 
has been identified as an interactor and downstream effector of ephrinB1 (Cowan and 
Henkemeyer 2001). Grb4, but not its related adaptor protein Nck (noncatalytic region 
of tyrosine kinase adaptor protein 1), binds to the phosphorylated cytoplasmic tail of 
ephrinB1 upon EphB2 engagement of ephrinB1 and induces loss of polymerized F-
actin structures, disassembly of focal adhesions and detachment of the cells from the 
substratum. This effect was accompanied by focal adhesion kinase (FAK) 
phosphorylation and redistribution of the focal adhesion protein paxillin from the 
plasma membrane, indicating regulated disassembly of focal adhesion sites. 
Moreover, EphB2-induced stimulation of ephrinB1 leads to recruitment of Grb4 and 
its SH3-binding partner c-Cbl-associated protein (CAP), from focal adhesions to 
localized regions of ephrinB1 activation (Figure 7b). 
 
4.2.2.1.2 Phosphorylation-independent signaling by ephrinB  
 
The cytoplasmic region of ephrinB ligands also contains a PDZ-binding motif (YKV) 
at its carboxyl terminus, which serves as docking site for both adaptor proteins that 
consist of only PDZ domains, such as GRIP1, GRIP2 as well as syntenin, and proteins 
containing PDZ domains and other protein domains, as for example protein kinase C-
interacting protein (PICK)1 and the tyrosine phosphatase PTP-BL (Figure 7). In most 
cases (except for PTP-BL), the functional relevance of these interactions in ephrinB1 
localization and clustering or reverse signaling events is not known. Another link that 
connects ephrin signaling in a phosphorylation-independent fashion to a functional 
read-out occurs through PDZ-RGS3, a cytoplasmic protein containing one PDZ and 
one “regulator of G-protein signaling” (RGS) domain, which binds constitutively to 
ephrinB ligands (Lu, Q. et al. 2001). RGS domains have a GAP activity for the  
subunit of heterotrimeric G-proteins, thereby serving as negative regulators of G-
protein signaling. EphrinB reverse signaling via PDZ-RGS interferes with the 
signaling of the chemokine stromal derived factor (SDF)-1 via its G-protein coupled 
receptor CXCR4. SDF-1 is an attractant for migrating cerebellar granule cells. The 
  4. Introduction 
  30 
inhibitory action of ephrinB reverse signaling was implicated in the correct layering of 
these cells during cerebellar development (Lu, Q. et al. 2001). 
 
 
 
Figure 7. EphrinB-mediated reverse signaling as described in the text. (a) Following 
activation of the ligand, ephrinB and Src family kinases (SFKs) are recruited to the same 
compartments and tyrosine phosphorylation of the ephrinB cytoplasmic tail via the activity of 
the SFK takes place. (b) Tyrosine phosphorylated residues act as docking sites for SH2-
containing molecules, such as Grb4, which transduce a phosphotyrosine-dependent signal to 
the interior of the cell inducing a rearrangement of the cytoskeleton. (c) PTP-BL 
dephosphorylates ephrinB ligands and inactivates Src and thereby switches phosphotyrosine-
dependent signaling off. (d) A variety of PDZ-domain containing proteins can now interact 
with the extreme carboxy-termini of ephrinB molecules. The chemokine SDF-1 binds to its 
G-protein-coupled receptor CXCR4 and activates signaling pathways through heterotrimeric 
G proteins. PDZ-RGS3, a GTPase-activating protein for heterotrimeric G proteins, binds 
constitutively to the PDZ-binding motif of ephrinB and reverses SDF-1-induced signaling by 
inactivating the α subunit of the heterotrimeric complex and therefore inhibiting chemotaxis. 
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4.2.2.1.3 EphrinB ligands and Rho proteins 
 
The Rho family of small GTPases has a central role in control of the dynamic 
reorganization of the actin cytoskeleton required for cell migration and adhesion (Hall 
and Nobes 2000). Although increasing evidence indicates that Eph receptors signal to 
the actin cytoskeleton via the Rho family of GTPases, little is known about the effects 
of ephrin reverse signaling on Rho family proteins. Some information comes from 
recent data showing that Dishevelled mediates RhoA and Rho kinase activation 
downstream of ephrinB1 (Tanaka et al. 2003). This demonstrates an important role for 
Dishevelled in both forward and reverse signaling downstream of EphB-ephrinB 
complexes. Another link between B-ephrins and RhoA may be src, which is required 
for ephrinB phosphorylation upon activation by EphB receptors (Palmer et al. 2002) 
and also phosphorylates p190RhoGAP (Brouns et al. 2001). However, the relevance 
of RhoA activation downstream of ephrins needs to be verified. Recently, there has 
been evidence that ephrin reverse signals activate Rac through the interaction of the 
Rac1-specific guanine nucleotide-exchanging factor TIAM1 with ephrinB1 and 
thereby mediate neurite outgrowth in cortical neurons (Tanaka et al. 2003).  
 
4.2.2.2 Signaling through GPI-anchored ligands 
 
Genetic studies indicated that the role of the single Caenorhabditis elegans Eph 
receptor (VAB-1) in cellular organization is, in part, kinase independent. This is in 
line with evidence from receptor-engaged C. elegans ephrinA, which mediates cell 
adhesion by activating the SFK member Fyn. Fyn kinase has been shown to co-
localize with the activated ephrinA ligand in lipid-raft microdomains (Davy et al. 
1999; Wang et al. 1999). Interestingly, available data consistently indicate that, in 
contrast to Eph receptors, ephrinA ligand activation, leads to enhanced integrin-
dependent adhesion (Davy et al. 1999; Davy and Robbins 2000; Huai and Drescher 
2001). Whereas the mechanisms for ephrinB signaling are beginning to be elucidated, 
as mentioned above, mechanisms for ephrinA reverse signaling, for which there is 
convincing biochemical and genetic evidence (Davy and Robbins 2000; Huai and 
Drescher 2001; Knoll et al. 2001; Holmberg et al. 2005), are largely unknown.  
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4.2.3 Ephs and ephrin functions in dendritic spine formation 
 
Using mainly cultured neurons, several reports have implicated EphB receptor 
forward signaling as a positive signal in spine formation. Postsynaptic EphB2, but not 
EphA receptor, has been shown to phosphorylate the cell-surface heparan-sulfate 
proteoglycan syndecan-2 on cytoplasmic tyrosine residues and to associate with 
syndecan-2 in a phosphorylation-dependent manner (Ethell et al. 2001). The same 
group had demonstrated before that syndecan-2 is able to promote spine maturation in 
cultured hippocampal neurons, presumably by recruiting a protein complex via its C-
terminus (Ethell and Yamaguchi 1999) (Figure 8). Inhibition of EphB2 signaling by 
overexpression of a kinase-inactive EphB2 mutant blocked endogenous syndecan-2 
clustering and spine formation. However, ultrastructural examination of synapse 
morphology has not revealed major changes in EphB2-null mutants, suggesting 
functional redundancy with other co-expressed Eph receptors (Grunwald et al. 2001; 
Henderson et al. 2001). Using EphB receptor triple knock-out mice, Henkemeyer and 
co-workers have now demonstrated a highly redundant requirement for three EphB 
receptors (EphB1, EphB2 and EphB3) in dendritic spine morphogenesis in the 
hippocampus (Henkemeyer et al. 2003). In vivo, few spines were still formed in triple 
mutants, whereas mutant cultured neurons completely lacked spines. The residual 
spines observed in vivo indicate the involvement of glial cells, which are more 
frequently present in vivo and might stabilize spines by enwrapping the synapses. 
Moreover, ephrinB2–mediated activation of the EphBs in vitro transformed thin 
immature spines into mature forms with spacious spine heads (Henkemeyer et al. 
2003). Downstream of EphB forward signaling, Moeller and colleagues very recently 
showed that shortening of dendritic filopodia involves the assembly of a complex, 
which includes focal adhesion kinase (FAK), Src, Grb2 (growth factor receptor-bound 
protein 2), and paxillin. Furthermore, EphB2 activation leads to the activations of 
FAK, Src, and paxillin, potentially initiating a number of downstream signaling 
pathways that are likely to contribute to the assembly of actin filaments in dendritic 
spines (Moeller et al. 2006). Rho-family GTPases have also been implicated in spine 
morphogenesis induced by Eph receptors (Irie and Yamaguchi 2002; Penzes et al. 
2003). Treatment of hippocampal neurons with soluble ephrinB1-Fc induced rapid 
formation of spine-like protrusions, which was blocked by overexpressing a kinase-
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inactive EphB2 mutant. EphB2 tyrosine kinase phosphorylated the endogenous 
RhoGEF kalirin in neurons, which was redistributed to larger and more synaptic 
clusters upon ephrinB1 stimulation. By using additional dominantly interfering tools, 
a pathway was outlined from Rho-GEF kalirin to filamentous actin formation and 
gene expression mediated by Rac1 and PAK, a key target of Rac1 (Penzes et al. 
2003). EphB2 also physically associates with RhoGEF intersectin and activates its 
GEF activity in cooperation with neural Wiskott-Aldrich syndrome protein (N-
WASP), which in turn upon stimulation with ephrinB2-Fc activates the Rho-family 
GTPase Cdc42 and spine morphogenesis (Irie and Yamaguchi 2002). EphrinB-
mediated activation of EphB receptors also induces tyrosine phosphorylation and 
recruitment to dendritic spines of another Rac1 exchange factor: TIAM1 (Tanaka et 
al. 2004; Tolias et al. 2005). Blocking TIAM1 function with dominant-negative 
mutants or by RNA interference causes a marked reduction in dendritic spine 
numbers, suggesting a role for TIAM1 in dendritic spine development. 
While axonal-dendritic spine formation may be regulated by ephrinB-EphB 
interactions, glial-dendritic control of spine formation may involve ephrinA-EphA4 
signaling. EphA receptors have recently been shown to regulate dendritic spine 
morphology in hippocampal slices obtained from adult mice (Murai et al. 2003). 
Comparison of wild-type with EphA4-/- slices revealed that spines lacking EphA4 
were irregular in shape and significantly shorter than normal. Murai and co-workers 
also found highest expression of ephrinA3 on astrocytic processes near synaptic 
terminals suggesting that neuroglia interactions involving ephrinA3 and EphA4 
forward signaling stabilize spine morphology and possibly synapses in the intact 
hippocampus. 
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Figure 8. Eph signaling pathways leading to spine formation. The proteoglycan syndecan-
2 mediates synaptic spine formation. Eph receptors activate syndecan-2 by phosphorylation. 
The RhoGEFs Kalirin-7 and TIAM1 have also been implicated in EphB-mediated formation 
of dendritic spines through recruitment and activation of the Rho GTPase Rac1 and PAK. The 
RhoGEF intersectin connects Eph signaling to Cdc42 inducing F-actin formation, a 
prerequisite of spine formation. Activation of EphB receptors results also in the association of 
FAK, Grb2, and Src with EphB2. Following assembly of this protein complex, Src is 
activated and phosphorylates FAK and paxillin, which results in RhoA activation and 
dendritic filopodia shortening. 
 
4.2.4 Ephrins and Ephs in synaptic plasticity 
 
Recent research has shown that Eph receptors and ephrins are important in the adult 
nervous system, for example during the processes of synapse formation and synaptic 
plasticity, which is dependent on neuronal activity. While control of spine formation 
by Eph/ephrin appears to involve redundant contributions from several family 
members, the signaling events leading to activity-dependent synaptic plasticity require 
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the presence of the EphB2 receptor, which is thought to act postsynaptically by 
modulating glutamate receptors (Grunwald et al. 2001; Henderson et al. 2001; 
Contractor et al. 2002) and which was shown to associate with and to induce 
clustering of NMDA receptors (Figure 9). This in turn may suggest that ephrinB 
ligands in synaptic membranes induce the maturation of glutamatergic synapses by 
promoting NMDA receptor aggregation (Dalva et al. 2000). A model in which ephrin-
Eph signaling influences activity-dependent processes (Ca2+ influx) by modulating 
gene expression during development of synaptic connections comes from data 
obtained from very young cultured neurons, which showed enhanced NMDAR-
mediated Ca2+ influx and potentiated cAMP-response element binding protein 
(CREB)-phosphorylation and -dependent transcriptional events upon stimulation with 
ephrinB1 (Grunwald et al. 2001; Takasu et al. 2002). This might mechanistically 
occur by the recruitment and activation of SFKs, which phosphorylate certain subunits 
of the NMDAR (Grunwald et al. 2001; Takasu et al. 2002) Activation of SFKs is 
required for EphB2-mediated enhancement of Ca2+ influx, at least in a transfected cell 
system (Takasu et al. 2002). These in vitro observations are consistent with findings 
from EphB2-deficient mice (Grunwald et al. 2001; Henderson et al. 2001) showing a 
reduction or even loss of hippocampal long-term potentiation and long-term 
depression correlated with a redistribution of a significant fraction of NMDA 
receptors. Interestingly, targeted expression of a kinase-deficient EphB2 receptor 
isoform rescued the defects in EphB2-deficient mice, suggesting that ephrinB ligand 
reverse signaling may be the active signaling partner at the synapse (Grunwald et al. 
2001; Henderson et al. 2001).  
Recent evidence indicates that in certain synapses, the Eph/ephrin system is used in an 
inverted manner: At the mossy fiber–CA3 synapse, ephrinB3 is specifically expressed 
by presynaptic dentate gyrus cells while the EphB2 receptor is expressed by both 
presynaptic dentate gyrus and postsynaptic CA3 neurons. In contrast, in the CA1 
region of the hippocampus, ephrinBs are predominantly localized in postsynaptic 
neurons, whereas EphBs and EphA4 are expressed both pre- and postsynaptically 
(Grunwald et al. 2004) (Figure 9). Interestingly, conditional mutants of ephrinB2- and 
ephrinB3-null mutants display drastically reduced LTP. Moreover, EphA4 forward-
signaling is not required since the deficit is rescued by an EphA4 receptor with the 
intracellular domain completely deleted. Therefore, EphA4 does not act as a receptor 
in the traditional sense, but rather as a ligand for postsynaptic and possibly 
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presynaptic ephrinBs, which are competent for reverse signaling. This supports a 
model in which the Eph/ephrin signaling system is used for activity-dependent 
plasticity in a converse fashion at different hippocampal synapses via an as-yet 
unknown pathway and, therefore, some of the spine morphology changes during 
plasticity might be regulated exclusively by ephrin reverse signaling pathways. Thus, 
ephrinB reverse signaling might be as important for dendritic spine development as 
the signaling pathways downstream of the Eph receptors. However, the ability of 
ephrins to initiate intracellular signals at synapses as well as the pathways involved in 
such signaling processes remain unknown. 
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Figure 9. Eph and ephrin signaling pathways in synaptic plasticity. EphB2 enhances 
NMDA-dependent calcium fluxes through the cytoplasmic tyrosine kinase Src, which 
phosphorylates the NMDA receptor and potentiates phosphorylation of CREB. CREB-
dependent transcriptional events, influenced by activity-independent EphB signaling, may 
affect synapse formation, maturation, and plasticity. In postsynaptic CA1 neurons, ephrinB 
reverse signaling is required for long-term plasticity. This raises the intriguing possibility that 
the bi-directional Eph/ephrin signaling system is used for activity-dependent plasticity in 
converse ways at different synapses. The signaling partners required for reverse signaling in 
the postsynaptic CA1 neurons remain unknown.  
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5. Results 
 
5.1 Grb4 and GIT1 transduce ephrinB reverse signals modulating 
 spine  morphogenesis and synapse formation 
 
Dendritic spines are small protrusions emerging from the dendrites that receive 
excitatory input. The process of spine morphogenesis occurs both in the developing 
brain and during synaptic plasticity. Molecules regulating cytoskeletal rearrangements 
have been involved in spine formation and maintenance. Work to be presented here 
will show that reverse signaling by the transmembrane ligands for Eph receptors, 
ephrinB ligands, is required for correct spine morphogenesis. The molecular 
mechanism underlying this function of ephrins involves the SH2/SH3 adaptor protein 
Grb4 and the signaling adaptor GIT1. Grb4 binds via its SH2 domain to Tyr392 in the 
synaptic localization domain (SLD) of GIT1. Phosphorylation of Tyr392 and the 
recruitment of GIT1 to synapses are regulated by ephrinB activation. Disruption of 
this pathway impairs spine morphogenesis and synapse formation. In the studies 
presented, an important role for ephrinB reverse signaling in spine formation has been 
shown and the required ephrinB reverse signaling pathway has been mapped. 
 
5.1.1 EphrinB ligand signaling promotes spine maturation and is required for 
 spine morphogenesis 
 
It has been previously shown that hippocampal neurons from triple EphB-deficient 
mice failed to make dendritic spines (Henkemeyer et al. 2003). EphrinB ligands are 
highly enriched in preparations of the postsynaptic density and they interact with 
postsynaptic proteins (Grunwald et al. 2004). In order to investigate if activation of 
ephrinB ligands at synapses promotes spine formation, we stimulated 12 DIV rat 
hippocampal neurons with a soluble pre-clustered form of EphB2 receptor 
ectodomain fused to the Fc portion of human IgG (EphB2-Fc). We transfected the 
neurons with Yellow Fluorescent Protein (YFP) at 7 DIV in order to visualize 
protrusions after stimulation. Activation of ephrinB ligands by EphB receptor induced 
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spine maturation reflected by the shortening of the spines and the appearance of 
mushroom-like heads (Figure 10a). The average length of spines was reduced from 
1.92 ± 0.19 µm in the Fc controls to 1.66 ± 0.02 µm in EphB2-Fc stimulated neurons. 
To interfere with ephrinB reverse signaling we transfected rat hippocampal neurons 
with a truncated form of ephrinB1 (ephrinB1-ΔC), which lacks the cytoplasmic 
domain and therefore is deficient in reverse signaling. EphrinB1-ΔC is expressed at 
the membrane and is able to bind to EphB receptors expressed in neighboring cells 
(Zimmer et al. 2003) therefore acting as a dominant negative molecule that will 
interfere with the binding of endogenous ephrinB ligands to EphB receptors. The 
morphology of the spines in neurons transfected with a control vector or Cyan 
Fluorescent Protein (CFP)-ephrinB1-ΔC was visualized by co-transfection at 7 DIV 
with YFP. Overexpression of the truncated ephrinB ligand induced a significant 
increase in immature filopodia-like protrusions without heads (Figure 10b). The 
average length of protrusions was increased from 1.91 ± 0.29 µm in the YFP 
transfected controls to 2.55 ± 0.03 µm in CFP-ephrinB1-ΔC transfected neurons. 
These results suggest that ephrinB reverse signaling promotes spine maturation and is 
necessary for correct spine development. 
 
 
 
 
 
 
 
 
 
 
 
_____________________________________________________________________ 
Figure 10. EphrinB ligand signaling and spine maturation. (a) Activation of ephrinB 
ligands promotes spine maturation. Rat hippocampal neurons at 7 DIV were transfected with 
YFP and stimulated at 12 DIV for 8 h with clustered EphB2-Fc or control Fc, fixed and 
analyzed for the morphology of dendritic protrusions. The length of dendritic protrusions 
(n>500) was quantified (bottom panels). Group A represents spines and group B represents 
dendritic filopodia based on the length. Bar, 2 μm. (b) Expression of truncated ephrinB 
ligands impairs spine formation. Rat hippocampal neurons were transfected at 7 DIV with 
YFP (left panels) or co-transfected with YFP and CFP-ephrinB1-∆C (right panels), fixed at 11 
DIV and analyzed for the morphology of dendritic protrusions. The length of dendritic 
protrusions (n>500) was quantified (bottom panels). Bars: (top) 20 μm; (bottom) 2 μm. 
   5. Results 
 
  40 
 
 
 
5. Results 
 
41 
5.1.2 Grb4 is enriched in post-synaptic densities and localizes to synapses in
 cultured hippocampal neurons 
 
We next attempted to elucidate the signaling events downstream of ephrinB ligands 
involved in spine formation. The SH2/SH3 adaptor Grb4 acts as a transducer from the 
phosphorylated ephrinB1 cytosolic domain to signaling pathways controlling the 
cytoskeleton (Cowan and Henkemeyer 2001). To investigate the involvement of Grb4 
in synapse formation, and to map the signaling pathway downstream of ephrinB 
ligands in such a process, we examined first the subcellular distribution of Grb4 in 
hippocampal neurons. We immunostained low density cultures using a specific anti-
Grb4 antibody (Figure 11a). In mature hippocampal neurons Grb4 showed 
characteristic synapse localization, accumulating in puncta along the neuronal 
processes. Double staining with the postsynaptic density protein PSD-95 confirmed 
the postsynaptic localization of Grb4. Presynaptic localization of Grb4 was also 
confirmed by double immunostaining with the presynaptic marker synaptophysin.  
To obtain biochemical evidence that Grb4 localizes to the PSD, PSD fractions were 
prepared from adult mouse hippocampus using standardized sucrose gradients and 
triton/sarcosyl extraction (Cho et al. 1992). To assess the quality of our PSD 
preparations, PSD-95 and synaptophysin were used as post- and presynaptic markers 
respectively. Western blot analysis of the PSD preparations showed Grb4 strongly 
enriched in the postsynaptic density (Figure 11b). These findings indicate that Grb4 
is positioned in the right place to mediate ephrinB reverse signaling necessary for 
synapse formation.  
 
 
 
 
_____________________________________________________________________ 
Figure 11. Grb4 localizes to synapses. (a) Grb4 colocalizes with both pre- and postsynaptic 
markers. Hippocampal neurons at 3 weeks in culture were immunostained for endogenous 
Grb4 (left column), PSD-95 (upper and middle panels in middle column) and synaptophysin 
(lower panel middle column). Enlargements of the area in boxes are shown at the bottom of 
the pictures as well as a merge of the two signals in the right column. Bars: 20 μm; 
(enlargements) 2 μm. (b) Grb4 is enriched in the postsynaptic density (PSD). Different PSD 
subfractions, non-PSD fraction and total brain homogenate were analyzed by Western 
Blotting for the presence of the indicated proteins. 
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5.1.3 GIT1 interacts with Grb4 and forms a triple complex together with 
 ephrinB1 in adult mice brain 
 
To further dissect the pathway directing spine morphology downstream of ephrinB 
ligands, a proteomic analysis of Grb4 binding proteins from a neuroblastoma cell line 
was performed using the TAP-LC-MS/MS methodology (see Methods). Tandem 
affinity purification (TAP) has emerged as a versatile method to efficiently purify 
protein complexes from cells in culture (reviewed in Bauer and Kuster 2003). GIT1 
(Cat1) and 2 (Cat2) as well as the p21-activated protein kinase (PAK)-interacting 
exchange factors αPIX (RhoGEF6, Cool-2) and βPIX (RhoGEF7, Cool-1) were all 
identified as putative Grb4-interacting proteins in our screen (Table 1).  
 
Protein name 
Arf GTPase-activating protein GIT1, Cat1  
Arf GTPase-activating protein GIT2, Cat2  
FKSG30 
Heat shock cognate protein 54 
hnRNP A2/B1 
inositol polyphosphate 5-phosphatase OCRL-1 
prolactin-inducible protein precursor 
Rho-GEF 6, Cool-2, αPIX 
Rho-GEF 7, Cool-1, βPIX 
similar to tubulin α-chain isotype m-α-6-mouse 
similar to tubulin, beta 5 
TPMSK3 (fragment) 
tropomyosin 1 (ALPHA) 
tropomyosin isoform 
tubulin α-2 chain 
voltage-gated sodium channel α-subunit 
 
Table 1. Shortlist of Grb4 interactors identified by tandem affinity purification from SK-N-
BE2 cell stably expressing Grb4-CTAP. 
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To validate the tandem affinity purification results, we tested the ability of Grb4 to 
associate with the novel interactor GIT1 in a biochemical IgG pull-down assay in 
HeLa cells. We transfected HeLa cells with Grb4-TAP, or TAP as a negative control, 
together with GIT1- or GIT2-Flag and incubated the cell lysates with rabbit IgG 
agarose beads, which pull down via the Protein A portion of the TAP affinity tag. 
Western blotting analysis of the IgG precipitates showed that GIT1- and GIT2-Flag 
were co-precipitated with Grb4-TAP and not detected in the co-precipitations with the 
control TAP (Figure 12a). These results were further confirmed by experiments 
showing endogenous GIT1 co-precipitating with Grb4-TAP in transfected HeLa cells 
(Figure 12b). We next asked whether Grb4 and GIT1 form a complex in vivo in the 
mouse brain. To address this question we performed co-immunoprecipitation 
experiments from adult mouse brain extracts using specific antibodies against these 
proteins. Immunoprecipitation with anti-Grb4 antibodies precipitated GIT1 and GIT2, 
but did not if pre-immunization serum was used (Figure 12c). These results indicate 
that Grb4 associates with GIT1 and GIT2 in vivo.  
To investigate the involvement of the Grb4-GIT1 complex in ephrinB reverse 
signaling, we attempted to precipitate a triple complex from adult mouse brain formed 
by ephrinB, Grb4 and GIT1 using EphB2-Fc. Whole-brain lysates were mixed with 
soluble EphB2-Fc, which had been pre-clustered with anti-human immunoglobulin-γ 
(IgG) to pull down ephrinB and any associated protein. In these experiments, Grb4 
and GIT1 were found to co-precipitate in vivo with ephrinB1 in brains of adult mice 
(Figure 12d). As a control, precipitation using unfused Fc did not co-precipitate any 
of these three molecules. Thus, Grb4 and GIT1 form a ternary complex with ephrinB 
ligand, suggesting a role of Grb4-GIT1 in ephrinB reverse signaling in adult mouse 
brain. To investigate whether GIT1 and Grb4 also play a role in Eph receptor forward 
signaling, we next tested the ability of GIT1 and Grb4 to bind to endogenous EphB 
receptor by using soluble ephrinB1-Fc pre-clustered with anti-human-IgG to co-
precipitate potential EphB binding proteins. GIT1 was shown to bind to EphB 
receptor from adult mouse brain, while Grb4 was not detectable in these ephrinB1-Fc-
pulldowns (Figure 12e and data not shown) indicating that GIT1 may be a general 
signaling compound downstream of the receptor and the ligand. In case of the 
receptor GIT1 appears not to be recruited by Grb4 but might be recruited instead by 
Nck, which has already been shown to interact with EphB receptors. 
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5.1.4 GIT1 binds to the SH2 domain of Grb4 via its synaptic localization 
 domain (SLD) 
 
As mentioned before, GIT1 is targeted to synapses by a newly identified synaptic 
localization domain (SLD) and the molecules acting upstream and targeting GIT1 to 
the synapses remained to be elucidated (Zhang, H. et al. 2003). Therefore, we next 
attempted to map the region of GIT1 that is involved in the association with Grb4. 
Deletion of the SLD in GIT1 (GIT1∆SLD) (Figure 13e) led to the disruption of its 
interaction with Grb4 (Figure 13a). Therefore, the SLD domain is necessary for the 
binding to Grb4. Moreover, the SLD domain is sufficient to associate with Grb4, 
since the isolated SLD domain co-precipitated with Grb4 in HeLa transfected cells 
(Figure 13b). To discard the possibility of a non-proper folding of the deletion mutant 
we next tested the ability of GIT1∆SLD to bind endogenous βPIX. βPIX was shown 
to bind to GIT1 via SHD-1 (Spa-homology domain 1) (Zhao et al. 2000a), and indeed 
endogenous βPIX was still able to interact with GIT1∆SLD in HeLa cells (Figure 
14a). The fact that βPIX has been found in our TAP/MS analysis may point to an 
indirect Grb4-βPIX interaction, which is likely to occur via GIT1. 
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Figure 12. GIT1 interacts with Grb4. (a) GIT1 and GIT2 interact with Grb4 in HeLa cells. 
Expression constructs of GIT1- and GIT2-Flag were co-expressed in HeLa cells with Grb4-
TAP or the isolated TAP-tag as control. IgG pulldowns were analyzed by Western blotting 
with the indicated antibodies. Grb4-TAP and TAP were detected by a peroxidase (POD)-
conjugated anti-POD antibody (PAP) antibody. (b) Endogenous GIT1 interacts with Grb4 in 
HeLa cells. HeLa cells were transiently transfected with Grb4-TAP or TAP as control. Total 
lysates and IgG pulldowns were analyzed by Western blotting with the indicated antibodies. 
(c) GIT1 and GIT2 associate with Grb4 in adult mouse brain. Whole brains from adult mice 
were lysed and immunoprecipitated with anti-GIT1, anti-GIT2, anti-Grb4 and pre-
immunization serum (pre-imm). The immunoprecipitates were analyzed by Western blotting 
for GIT1 (upper panel) and GIT2 (lower panel). (d) GIT1 forms a triple complex with Grb4 
and ephrinB1 in adult mouse brain. Whole brain lysates were incubated with EphB2-Fc to 
precipitate ephrinB or with Fc as a control. Precipitates were analyzed by Western blotting for 
GIT1 and ephrinB1 (upper panel) and GIT1 and Grb4 (lower panel). (e) GIT1 also interacts 
with EphB receptor in adult mouse brain. Whole brain lysates were incubated with ephrinB1-
Fc to precipitate EphB or with Fc as a control. Precipitates were analyzed by Western blotting 
for EphB2 (upper panel) and GIT1 (lower panel). p.d.: pull down 
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Figure 13. GIT1 binds to Grb4 through its synaptic localization domain (SLD). (a) Grb4 
does not bind to SLD-deficient GIT1. Expression constructs of GIT1- (left panel) and 
GIT1∆SLD-Flag (right panel) were co-expressed in HeLa cells with Grb4-YFP. Flag-
immunoprecipitates were analyzed by Western blotting with the indicated antibodies. (b) SLD 
in GIT1 is sufficient to bind to Grb4. HeLa cells were transiently co-transfected with SLD-V5 
and Grb4-YFP. V5-immunoprecipitates were analyzed by Western blotting with the indicated 
antibodies. (c) Grb4 binds to GIT1 via its SH2 domain. HeLa cells were transiently 
transfected with full length Grb4, Grb4-SH2 and Grb4-SH3 (containing all three native SH3 
domains) all fused to YFP. The GFP-immunoprecipitates were analyzed by Western blotting 
with anti-GFP and anti-GIT1 to detect endogenous GIT1. (d) Grb4 binds to ephrinB1 through 
its SH2 and SH3 domains. Expression constructs of full length Grb4-YFP, Grb4 SH2-YFP 
and Grb4 SH3-YFP were co-expressed in HeLa cells with HA-ephrinB1. HA-
immunoprecipitates were analyzed by Western blotting with the indicated antibodies. (e) 
Schematic diagram of the full-length and deletion constructs of GIT1 and Grb4. The indicated 
domains are as follows: ADP-ribosylation factor (ARF)-GAP domain (Arf-GAP), ankyrin 
repeats (Ankyrin), Spa2 homology domain 1 (SHD-1), synaptic localization domain (SLD), 
paxillin binding site (paxillin), Src homology domain 3 (SH3) and Src homology domain 2 
(SH2). pre: pre-immunization serum 
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Grb4 comprises three N-terminal SH3 domains and one C-terminal SH2 domain 
(Braverman and Quilliam 1999). To analyze the domains of Grb4 that are involved in 
the association with GIT1, we generated two YFP-fusion proteins, which contain 
either all three Grb4 SH3 domains (Grb4 SH3-YFP) or the Grb4 SH2 domain (Grb4 
SH2-YFP), and tested their ability to interact with GIT1. Equal amounts of YFP-
tagged Grb4, SH2 and SH3 were recovered from all transfected cells by 
immunoprecipitation with the anti-GFP antibody (Figure 13c). Endogenous GIT1, 
however, was only detected in the anti-GFP immunoprecipitates from HeLa cell 
lysates expressing either full-length Grb4-YFP or Grb4 SH2-YFP. Grb4 SH3-YFP 
was not able to interact with GIT1. These results were further confirmed by the 
converse immunoprecipitation experiments in which Grb4-YFP and Grb4 SH2-YFP 
were co-precipitated with GIT1-Flag (Figure 14c). Association of transfected YFP-
fusion proteins Grb4 and SH3, but not SH2 to endogenous protein kinase C-related 
kinase (PRK2) (Figure 14b), as shown previously (Braverman and Quilliam 1999), 
demonstrated a proper folding of Grb4 SH3-YFP.  
Grb4 SH2 domain has previously been shown to bind to phosphorylated ephrinB 
ligands (Cowan and Henkemeyer 2001). Since we postulate the existence of a triple 
complex containing ephrinB ligands, Grb4 and GIT1, and Grb4 binds to GIT1 by its 
SH2 domain, we next investigated the possibility that the Grb4 molecules involved in 
such a complex would bind to ephrinB by the SH3 domains. We co-transfected HeLa 
cells with YFP-tagged Grb4, Grb4 SH2 and Grb4 SH3 together with HA-ephrinB1. 
HA-immunoprecipitates revealed the association of ephrinB1 with both the SH2 and 
the SH3 domains of Grb4, suggesting that Grb4 is also able to interact with ephrinB 
ligands via its SH3 domains (Figure 13d).  
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Figure 14. GIT1- and Grb4-deletion constructs are properly folded and bind to know 
interactors. (a) SLD-deficient GIT1 (GIT1∆SLD) is still able to interact with βPIX. HeLa 
cells transiently expressing GIT1-Flag or GIT1∆SLD-Flag were lysed, immunoprecipitated 
(IP) with pre-immunization serum (pre) or anti-Flag antibodies and analyzed by Western 
blotting with anti-Flag and anti-βPIX antibodies to detect endogenous βPIX. (b) SH2-
deficient Grb4 (Grb4 SH3) still interacts with PRK2. HeLa cells were transiently transfected 
with full length Grb4, Grb4 SH2 or Grb4 SH3 (containing all three native SH3 domains) all 
fused to YFP. The GFP-immunoprecipitates were analyzed by Western blotting with anti-
GFP and anti-PRK2 to detect endogenous PRK2. (c) GIT1 associates with the SH2 domain of 
Grb4. HeLa cells were transiently co-transfected with GIT1-Flag and full length Grb4-, Grb4 
SH2- or Grb4 SH3-YFP. Flag-immunoprecipitates were analyzed by Western blotting with 
anti-GFP and anti-Flag antibodies.  
 
5.1.5 Tyr392 in the SLD of GIT1 is required for Grb4 binding  
 
The fact that the SLD domain of GIT1 binds to the SH2 domain of Grb4 suggests that 
tyrosine phosphorylation sites in SLD mediate such binding. Among the 5 tyrosine 
residues in the SLD domain, only Tyr392 in the N-terminus was predicted by Netphos 
software (http://www.cbs.dtu.dk/services/NetPhos) to be phosphorylated with high 
probability. Interestingly, Tyr392 resides in a region of 32 aa in the N-terminus of the 
SLD and the deletion of this region has been demonstrated to significantly decrease 
the localization of GIT1 to synapses (Zhang, H. et al. 2003). We therefore mutated the 
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tyrosine 392 in GIT1 into phenylalanine (Y392>F), a non-phosphorylatable aa, to test 
its requirement for the interaction with Grb4. Equal amounts of Flag-tagged wild-type 
GIT1 and mutated GIT1Y392>F were recovered from all transfected cells by 
immunoprecipitation with the anti-Flag antibody (Figure 15a). While Grb4-YFP co-
precipitated with wild-type GIT1-Flag in HeLa cells, the mutation in GIT1Y392>F-
Flag led to a disruption of the interaction of Grb4-YFP with GIT1. Reverse 
immunoprecipitation of Grb4-YFP lead to the same results: only GIT1 wild type and 
not the mutant was co-precipitated with Grb4 (Figure 15a). Therefore, these findings 
suggest that phosphorylation of tyrosine 392 in the SLD domain of GIT1 is required 
for the interaction with Grb4. The kinase responsible for such phosphorylation is so 
far unknown.  
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5.1.6 EphrinB reverse signaling induces the phosphorylation of GIT1 in Tyr392 
 and the formation of a Grb4-GIT1 complex 
 
Since Tyr392 was required for GIT1-Grb4 binding, we next investigated whether 
activation of ephrinB ligands would lead to phosphorylation of the SLD domain in 
Tyr392. We transfected HeLa cells stably expressing ephrinB1 (HeLa-ephrinB1) with 
SLD-YFP and, to follow the kinetics of phosphorylation of SLD, we stimulated the 
cells for 5, 15 and 45 minutes with pre-clustered EphB2-Fc (Figure 15b). Equal 
amounts of SLD-YFP were recovered from all transfected cells by 
immunoprecipitation with the anti-GFP antibody. Immunoblotting with anti-
phosphotyrosine antibody 4G10 revealed a transient, rapid increase of phosphorylated 
SLD-YFP after 5 minutes stimulation, which returned to baseline by 45 minutes.  
Moreover, we also investigated whether the binding of GIT1 to Grb4 was regulated 
directly by ephrinB ligand activation. We transfected HeLa-ephrinB1 cells with Grb4-
YFP and analyzed the binding of endogenous GIT1 to Grb4 after stimulation with 
EphB2-Fc (Figure 15c). After 5 minutes stimulation with pre-clustered EphB2-Fc, 
GFP-immunoprecipitates already showed endogenous GIT1 binding to Grb4. In 
agreement with the kinetics of phosphorylation of the SLD, the Grb4-GIT1 complex 
was transient and decreased after 45 minutes. GIT1 was practically undetectable in 
immunoprecipitates from Fc-stimulated cells. 
 
 
_____________________________________________________________________ 
Figure 15. Grb4-GIT1 binding is regulated by ephrinB reverse signaling. (a) The 
Y392>F mutation in GIT1 abolishes the binding of Grb4. Expression constructs of GIT1- or 
GIT1 Y392>F-Flag were co-expressed in HeLa cells with Grb4-YFP. Flag- (left panels) and 
GFP-immunoprecipitates (right panels) were analyzed by Western blotting with the indicated 
antibodies. (b) Tyrosine phosphorylation in SLD is induced upon ephrinB ligand activation. 
HeLa-ephrinB1 cells were transiently transfected with SLD-YFP and stimulated with pre-
clustered EphB2-Fc or Fc for the indicated time points. Total lysate were analyzed for levels 
of transfected SDL-YFP (lower panel) and were immunoprecipitated with anti-GFP and 
analyzed by immunoblotting with α-P-Tyr (4G10) (upper panel) and anti-GFP (middle panel). 
(c) GIT1 is recruited to Grb4 after ephrinB ligand activation. Full length Grb4-YFP was 
expressed in HeLa-ephrinB1 cells. Cells were stimulated with pre-clustered EphB2-Fc or Fc 
for the indicated time points and GFP-immunoprecipitates were analyzed by Western blotting 
for endogenous GIT1 (upper panel) and for Grb4-YFP levels. (d) Schematic diagram of the 
SLD including Tyr392 required for binding of Grb4 and present in the NH2-terminal 32 
amino acids, which have been previously shown to contribute to efficient synaptic 
localization.  
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5.1.7 Stimulation with EphB receptors recruits GIT1 to ephrinB patches at the 
 synapse in hippocampal neurons 
 
We next investigated the subcellular distribution of GIT1 in hippocampal neurons and 
its behavior after stimulation of those neurons with EphB receptors. We stimulated 
dissociated hippocampal neurons (14 DIV) for 10 minutes with pre-clustered EphB2-
Fc (Figure 16i-p) or Fc as a control (Figure 16a-h). Stimulation with EphB2-Fc, but 
not Fc, induced the formation of large clusters at the membrane visualized with anti-
human Fc antibody conjugated to TexasRed (Figure 16j, n). Triple immunostainings 
with anti-human Fc, anti-GIT1 and anti-PSD-95 antibodies revealed a redistribution 
of endogenous GIT1 protein into clusters along the neuronal processes that 
overlapped with EphB/ephrinB complexes and postsynaptic marker proteins in 
EphB2-Fc-stimulated neurons (Figure 16m-p), but not in unstimulated neurons 
(Figure 16e-h). Together these data indicate that GIT1 colocalizes in a regulated 
fashion with activated ephrinB in postsynaptic synapses of living neurons. 
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Figure 16. GIT1 is recruited to ephrin patches at the synapse. GIT1 is recruited to ephrin 
patches at the synapse. Primary rat hippocampal neurons isolated from E18.5 rats were 
cultured and were stimulated at 14 DIV with Fc (a-h) or EphB2-Fc (i-p). Receptor bodies, 
bound to ephrinB ligand, were visualized with an anti-human Fc antibody conjugated to 
TexasRed (j, n). Fc-stimulated neurons showed only background staining (b, f). Distribution 
of endogenous proteins detected with an anti-GIT1 polyclonal (c, g, k, o) and an anti-PSD-95 
monoclonal antibody (d, h, l, p) is shown. In the merge panels (a, e, i, m), the three signals are 
shown: GIT1 (green), receptor bodies (red) and PSD-95 (blue). Bars: (top) 20 μm; (bottom) 2 
μm. 
 
5.1.8 Disruption of ephrinB signaling via Grb4 and GIT1 affects spine 
 morphogenesis and synapse formation 
 
To further define the physiological significance of ephrinB/Grb4/GIT1 signaling in 
spine formation, we attempted to interfere with this signaling pathway by expressing 
two different dominant negative constructs in neurons: (1) the Grb4 SH2 domain, 
which interferes with the binding of endogenous GIT1 to Grb4, and (2) a small 
interfering ephrinB peptide containing the shortest sequence within the intracellular 
domain of ephrinB1 required for interaction with Grb4 (Cowan and Henkemeyer 
2001), which competes away the complex Grb4-GIT1 from ephrinB ligands. As 
reported previously, hippocampal neurons in culture require approximately 3 weeks to 
fully develop mature spines under normal conditions. Before 10 DIV, the majority of 
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dendritic protrusions are long, filopodia-like structures (Ethell and Yamaguchi 1999). 
It was previously shown that the expression of the SLD domain of GIT1 induced an 
increase in long and thin dendritic filopodia-like protrusions, suggesting that 
perturbing GIT1 localization results in defects in spine morphology and synapse 
formation (Zhang, H. et al. 2003). Here we show that neurons expressing Grb4 SH2 
domain and the ephrinB1 peptide fused to YFP, presented a high increase in the 
number of long, thin dendritic protrusions (Figure 17a). The average length of 
protrusions was increased from 1.86 ± 0.04 µm in the YFP-transfected controls to 
2.01 ± 0.01 µm in the Grb4 SH2-YFP and 2.23 ± 0.02 µm in the ephrinB1-313-335-
YFP transfected neurons (Figure 17b). In addition, in the Grb4 SH2 domain and 
ephrin peptide expressing neurons, the linear density of dendritic protrusions (number 
of protrusions per 100 µm dendrite) increased significantly compared with neurons 
expressing YFP (Figure 17c). Thus, these data suggest that perturbing Grb4-GIT1 
recruitment to ephrinB ligands at the synapse is crucial for normal spine 
morphogenesis. The morphological formation and maturation of spines in normal 
cultured hippocampal neurons directly correlates with synapse formation (Ethell and 
Yamaguchi 1999). We next asked if neurons, which fail to make proper mushroom-
shaped spines develop correct synapses. We analyzed synapse formation by counting 
the number of clusters of the pre-synaptic protein synapsin1. In the Grb4 SH2- and 
ephrinB1 peptide-expressing neurons the linear density of synapses (number of 
synapses per 100-μm dendrite) decreased significantly as compared to neurons 
expressing YFP (Figure 17d, e). This is consistent with previous findings in neurons 
overexpressing GIT1-SLD, which also showed decreased synapsin1 staining (Zhang, 
H. et al. 2003). These results suggest that the proper localization of the Grb4-GIT1 
complex is not only necessary for the formation of spines, but is also important for 
synapse formation. 
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Figure 17. Disruption of ephrinB signaling through Grb4 and GIT1 affects spine 
morphogenesis and synapse formation. (a) Rat hippocampal neurons were transfected at 7 
DIV with YFP as control, Grb4 SH2-YFP or YFP-ephrinB1-313-335, fixed at 11 DIV and 
examined. Bars: (top) 20 μm; (bottom) 2 μm. (b-c) Quantification of the length (b) and 
density (c) of dendritic protrusions (n>500) analyzed for each transfection condition. Bars 
represent standard error of the mean. *, P<0.05, **, P<0.005, ***, P<0.0005. (d) Effects of 
Grb4 SH2-YFP and YFP-ephrinB1-313-335 expression on synaptic density. Rat hippocampal 
neurons were transfected with the indicated constructs at 7 DIV and stained for synapsin1 
(right panel) at 11 DIV. Bars, 2 μm. (e) Quantification of synaptic linear density analyzed for 
each transfection condition. Synapse formation was analyzed by numbers of synapsin1-
positive immunoreactivities. 
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5.2 Proteomic analysis of PDZ-mediated ephrinB reverse signaling 
 
To identify new components involved in PDZ domain-mediated reverse signaling 
downstream of ephrinB ligands, we used the tandem affinity purification (TAP) 
strategy. The TAP procedure is a sensitive and selective method to purify, under 
close-to-physiological conditions, multiprotein complexes formed in vivo (Rigaut et 
al. 1999; Gavin et al. 2002). We chose to TAP-tag the known PDZ domain-containing 
ephrinB interactor GRIP1 (Bruckner et al. 1999), which has recently been 
demonstrated to be recruited to ephrinB ligand in so-called raft membrane 
microdomain signaling centers. This TAP approach revealed a set of several novel 
GRIP1 interactors. Association with one new binding partner, 14-3-3 proteins, was 
further characterized and found to be restricted to raft membrane microdomains. A 
single Thr residue in a putative 14-3-3 binding site in GRIP1 was identified and 
shown to be required for the formation of the GRIP1-14-3-3 complex. Moreover, we 
have also applied the TAP technology in vivo. Transgenic mice expressing GRIP1-
CTAP were generated and the tagged protein shown to form functional complexes in 
those mice.  
 
5.2.1 Identification of GRIP1 complexes by tandem affinity purification 
 
After stable integration into SK-N-BE2 cells by retrovirus-mediated gene transfer, the 
tagged protein was purified and TAP/MS analysis of the protein complexes formed 
around GRIP1 was performed. Infected clones were subjected to tandem affinity 
purification, a procedure consisting of two specific binding and elution steps under 
mild conditions, which preserve the integrity of non-transient protein-protein 
interactions (Rigaut et al. 1999) (Figure 18). The affinity-purified complexes were 
resolved on SDS-PAGE and Coomassie-stained (Figure 19a). GRIP1 interactors were 
identified by peptide sequencing using tandem mass spectrometry (LC-MS/MS). A 
database generated by large scale TAP analysis in this cell line has been assembled by 
collaborators at Cellzome AG (Heidelberg) containing a high number of protein-
protein interactions and allowing the reliable assessment of the specificity of a given 
interaction (data not shown). Cellzome has also identified a set of potentially sticky 
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proteins, suspected to purify nonspecifically in the TAP method, which provides 
information about molecules, which are very likely to be false positives and should 
therefore be excluded from any further validation. In total, the raw data set contained 
134 non-redundant protein hits. Among those 132 interactors in total, 73 (54%) were 
considered to be sticky (Table 2) due to their frequent identification as interactors of 
various TAP-tagged molecules. The remaining 59 interactors (Table 2) were to be 
selected for further validation by literature screening on the basis of potential 
relevance in ephrinB reverse signaling.  
 
 
 
Figure 18. Overview of the Tandem Affinity Purification (TAP) strategy. The TAP tag 
comprises CBP (Calmodulin binding peptide) linked to a Protein A immunoglobulin (Ig)G-
binding domain separated by a tobacco etch virus (TEV) protease cleavage site. The 
purification of tissue or cell lysate consists of four specific steps: first, high affinity binding to 
IgG beads; second, elution using TEV protease; third, high-affinity binding to calmodulin 
beads in the presence of Ca2+; and finally, elution using Ca2+-chelating agents. 
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Protein name 
14-3-3 protein beta/alpha inositol polyphosphate 5-phosphatase OCRL-1 
14-3-3 protein eta L-lactate dehydrogenase A chain 
14-3-3 protein sigma myosin heavy chain, smooth-muscle isoform 
14-3-3 protein tau myosin IC 
26S proteasome non-ATPase regulatory subunit 2 myosin light chain 1, slow-twitch muscle A 
ADP-ribosylation factor 4 myosin light chain alkali, smooth-muscle 
ATP-dependent DNA helicase II, 70 kDa subunit myosin, light polypeptide, non-sarcomeric 
ATP-dependent DNA helicase II, 80 kDa subunit neurabin II protein, spinophilin 
cystatin A prolactin-inducible protein precursor 
DNA replication licensing factor MCM7 SCO2 protein homolog 
dopamine beta-hydroxylase precursor similar to FKSG30 
dopamine beta-monooxygenase precursor similar to heat shock 70KD protein 8 
emilin precursor similar to hnRNP A/B 
endothelin-A receptor delta 3-4 similar to hnRNP A2/B1 
enhancer of polycomb 1 similar to hnRNP Q2 
erythrocyte tropomodulin A similar to neu differentiation factor - human  
eukaryotic translation initiation factor 3 subunit 2 similar to RIKEN cDNA 1200016G03 
extracellular glycoprotein lacritin precursor similar to synovial sarcoma, X breakpoint 4 
FKSG30 similar to T-complex protein 10A - human 
glial fibrillary acidic protein, astrocyte similar to tropomyosin 1 (alpha) 
growth-arrest-specific protein 1 similar to tropomyosin, fibroblast - human 
GRY-RBP similar to tubulin α-chain, m-α-6 - mouse 
heat shock 27 kDa protein ssDNA-binding protein, mitochondrial precursor 
heat shock cognate protein 54 TPMSK3 (fragment) 
heat shock-related 70 kDa protein 2 tropomyosin 1 (alpha) 
hnRNP A2/B1 tropomyosin 1 alpha chain 
histone H2A.F/Z variant, isoform 1 tropomyosin isoform 
histone H2A.Z hypothetical protein FLJ12427 
hypothetical protein (fragment) tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein  
IKAPPAB kinase complex-associated protein  
 
Table 2. Shortlist of GRIP1 interactors identified by tandem affinity purification from SK-
N-BE2 cells stably expressing GRIP1-CTAP. 
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5.2.1.1 Identification of 14-3-3 as a GRIP1 binding protein 
 
14-3-3, a key regulator of cell division, signaling and apoptosis (van Hemert et al. 
2001), was identified with high confidence as a GRIP1 interactor. All 7 mammalian 
14-3-3-isoforms (β, γ, ε, η, σ, τ and ) were isolated by tandem affinity purification of 
GRIP1-CTAP in SK-N-BE2 cells. Further data has confirmed this interaction by 
reciprocal protein complex purification of 14-3-3-CTAP in the same cell line 
(Cellzome, personal communication). 14-3-3 proteins are highly conserved small 
acidic proteins, which, in most cases, regulate cellular processes by binding to specific 
pSer and pThr motifs within target proteins (Muslin et al. 1996). Two optimal 14-3-3 
phosphopeptide ligands with the consensus sequences RSXpS/TXP and 
RX(Y/F)XpS/TXP [where pS/T represents phosphoserine or phosphothreonine and X 
is any amino acid] have been defined (Yaffe et al. 1997). The roles of 14-3-3 proteins 
in cells have been classified on the basis of their mode of action. 14-3-3 proteins can 
for example induce conformational changes in target proteins as well as occlude 
specific sequences or structural features (reviewed in Mackintosh 2004). For all their 
regulatory functions 14-3-3 proteins need to associate in stable homo- and 
heterodimers (Chaudhri et al. 2003). The complexity of 14-3-3 actions is reflected by 
the increasing number of binding partners identified. Several studies have used tagged 
14-3-3 proteins to purify protein complexes from cells in culture (Jin et al. 2004; 
Meek et al. 2004; Pozuelo Rubio et al. 2004). 14-3-3 proteins are abundant in brain 
tissues and, although only few binding partners in brain have been so far postulated, 
14-3-3 proteins are clearly critical for brain development, memory and learning, and 
have been implicated as well in several neurological disorders (reviewed in 
Mackintosh 2004). 
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5.2.1.2 14-3-3 interacts with GRIP1 in total mouse brain lysate and forms a 
 complex with GRIP1 exclusively in raft membrane microdomains 
 
To confirm these interactions, we performed co-immunoprecipitation experiments 
from adult mouse brain extracts using a pan-antibody against 14-3-3. 
Immunoprecipitation with pan-14-3-3 antibodies co-precipitated GRIP1, but did not if 
pre-immunization serum was used (Figure 19b). Moreover, reverse co-
immunoprecipitation pulling down GRIP1 with a specific antibody confirmed the 
interaction with 14-3-3 (Figure 19b) indicating that GRIP1 associates with 14-3-3 in 
vivo. In an attempt to address the functional significance of GRIP1-14-3-3 interaction, 
we analyzed whether these complexes occurred in raft membrane microdomains, 
which have been implicated in processes such as sorting in polarized cells and signal 
transduction. The ligand ephrinB1 has been described, upon stimulation with EphB2 
receptor, to associate with GRIP1 in large raft patches that also contain a GRIP1-
associated serine/threonine kinase activity (Bruckner et al. 1999). Triton X-100 
(TX100)-insoluble raft membrane proteins can be identified by their ability, due to 
their high lipid content, to float in TX100-containing density flotation gradients as 
detergent-insoluble glycolipid-enriched complexes (DIGs) (Brown, D. A. and Rose 
1992). This property clearly distinguishes them from insoluble complexes formed by 
the cytoskeleton. As shown in Figure 19c and d (bottom panel), GRIP1 and 14-3-3 
are both found in the top fractions of the flotation gradient, indicating raft localization, 
as well as in non-raft fractions of adult mice brain. However, despite of the presence 
of the two proteins in rafts and non-rafts, GRIP1 can only be co-immunoprecipitated 
using an anti-14-3-3 antibody from the lipid-associated fraction 1 indicating 
localization of the GRIP1-14-3-3 complex exclusively in rafts of mouse tissue 
(Figure 19d, top panel). Since patches of raft domains are generally considered as 
signaling centers (Harder et al. 1998) these results show that interaction of the two 
molecules, may be regulated by a stimulus-dependent mechanism (e.g. Eph receptor 
stimulation), consistent with an important function in signal transduction . 
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5.2.1.3 EphrinB ligand, GRIP1 and 14-3-3 form a triple complex in raft 
 membrane microdomains of mouse brain  
 
We next wanted to see whether ephrinB reverse signaling might play a role in 
recruiting the GRIP1-14-3-3 complex to rafts. EphrinB1 interaction with GRIP2 is 
regulated by EphB2 receptor binding in NIH3T3 cells stably expressing ephrinB1 and 
GRIP2 (Manuel Zimmer, personal communication). Thus we immunoprecipitated 
ephrinB from raft and non-raft fractions of mouse brain using a specific antibody. 
Western Blot analysis revealed a triple ephrinB-GRIP1-14-3-3 complex that 
exclusively occurs in raft fractions (Figure 20). As shown in Figure 20, in non-rafts 
only ephrinB and 14-3-3 interact, albeit to a much lesser extent as compared to the raft 
fraction. The non-raft fractions of 14-3-3 seem to be of different isoform composition 
compared to the 14-3-3 fraction, which is detergent insoluble located (Figure 19c). 
These findings suggest that 14-3-3 may occur in two different pools, possibly as two 
different isomers: one pool of 14-3-3 interacting with GRIP1 upon its phosphorylation 
and subsequent recruitment to ephrinB ligand, and the other pool might be associated 
with the ligand with different regulatory purposes. 
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Figure 19. Tandem affinity purification of GRIP1-CTAP reveals new GRIP1 interactor. 
(a) Coomassie-stained SDS-PAGE lane showing tandem affinity-purified GRIP1-CTAP. TAP 
complexes were run on a NuPAGE 4-12% Bis-Tris gel with MOPS running buffer and 
complete gel lane was then systematically cut into slices and proteins were digested in-gel 
with trypsin. Protein identification was performed by LC–MS/MS. (b) 14-3-3 associates with 
GRIP1 in brain of adult mice. Whole brains from adult mice were lysed and 
immunoprecipitated with anti-14-3-3, anti-GRIP1 and pre-immunization serum. The total 
lysates and immunoprecipitates were analyzed by Western blotting for 14-3-3 and GRIP1. (c) 
A membrane preparation of an adult mouse brain homogenate was subjected to TX100 
flotation followed by Optiprep flotation gradients. Seven fractions from top to bottom were 
collected and analyzed by Western Blotting for the presence of 14-3-3 and GRIP1 proteins. 
Caveolin and transferrin receptor serve as raft-associated and nonraft proteins, respectively, 
confirming specificity of the preparation. (d) 14-3-3 interacts with GRIP1 exclusively in rafts. 
Three fractions from top to bottom were collected and analyzed by Western Blotting for the 
presence of 14-3-3 and GRIP1 proteins (bottom panel). 14-3-3 immunoprecipitates were 
analyzed by Western Blotting for the presence of 14-3-3 and GRIP1 proteins (top panel). 
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Figure 20. 14-3-3 forms a triple complex with ephrinB and GRIP1 in rafts. One DIG-
enriched fraction and two nonraft fractions were immunoprecipitated (IP) with anti-ephrinB. 
The immunoprecipitates were analyzed by Western blotting for GRIP1, 14-3-3 and ephrinB.  
 
5.2.1.4 Thr956 between GRIP1 PDZ6 and PDZ7 is required for 14-3-3 binding 
 
The data obtained demonstrate that 14-3-3 interacts with GRIP1. Sequence analysis to 
identify motif(s) in GRIP1 contributing to 14-3-3 binding showed three putative 14-3-
3 binding sites inside the linker region between PDZ6 and PDZ7 (852-857, 941-946, 
953-958). These sites exactly match the optimal sequence motif of a recognition site I 
(Muslin et al. 1996; Yaffe et al. 1997) and either contain a serine or a threonine 
residue at position 0 (Figure 21a). To investigate the contribution of these putative 
recognition motifs to interaction between GRIP and 14-3-3, we mutated serine 944 
and/or threonine 956 in GRIP1 into alanine, thus altering these residues predicted to 
be critical for the interaction with 14-3-3. Equal amounts of HA-tagged wild-type 14-
3-3 was recovered from all transfected cells by immunoprecipitation with the anti-HA 
antibody (Figure 21b). While GRIP1-myc and GRIP1S944>A-myc co-precipitated 
with wild-type HA-14-3-3 in HeLa cells, the mutation in GRIP1T956>A-myc led to a 
disruption of the interaction of HA-14-3-3 with GRIP1. Mutation analysis of GRIP1 
thus indicates a requirement of the most C-terminal 14-3-3 binding site, spanning aa 
953-958, for the interaction with 14-3-3. The kinase responsible for such 
phosphorylation is currently unknown. Identification of such kinase as well as the 
significance of Thr956 for GRIP1 function in vivo will be pursued in future studies. 
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Figure 21. Thr956 in PDZ6 of GRIP1 is required for 14-3-3 binding. (a) Amino acid 
sequence of rat GRIP1. The depicted sequence contains three putative 14-3-3 binding sites in 
the linker region between PDZ6 and PDZ7 (indicated by red letters). Individual PDZ domains 
are underlined by closed horizontal bars. (b) The T956>A mutation in GRIP1 abolishes the 
binding of 14-3-3. Expression constructs of myc-tagged GRIP1 w.t. and GRIP1-S944>A, -
T956>A or -S944+T956>A (S/T-A) were co-expressed in HeLa cells with HA-14-3-3. HA-
immunoprecipitates (right panel) were analyzed by Western blotting with the indicated 
antibodies. 
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5.2.2 Transgenic expression of GRIP1 in mice to identify protein complexes in 
 vivo 
 
We also applied the TAP technology to identify in vivo interactors with GRIP. We 
generated transgenic mice expressing GRIP1-TAP under the control of the human 
ubiquitin C promoter (Ubi-GRIP1-CTAP). This promoter contains a 1,225-bp 
fragment of the human ubiquitin C promoter and directs ubiquitous expression to 
most mouse tissues (Schorpp et al. 1996). The TAP approach in transgenic mice has 
several advantages over other methods for identification of protein-protein 
interactions: (a) the use of an in vivo model; (b) the purification of a protein complex 
that has been established in its natural environment, and (c) the possibility of 
comparison of protein complexes derived from different tissues and at different 
developmental stages. 
 
5.2.2.1 Transgenic GRIP1-CTAP is expressed in the brain of some founders  
 
Eight founders of the transgenic line expressing GRIP1-CTAP driven by the ubiquitin 
C promoter gave offspring. UbiGRIP1-CTAP transgenic mice in a C57BL/6 genetic 
background were fertile and did not show any gross phenotypic abnormalities. As 
shown in Figure 22a, compared to wild-type brain only five lines showed expression 
in the brain, of which two lines yielded strong (founders 540864 and 540874) and 
three lines weak expression levels (founders 540863, 540870 and 541026). The weak 
expressors together with those that did not display any expression (540870, 540867 
and 540875) were excluded from further analysis. The two lines displaying the 
strongest signal (founders 540864 and 540874) were selected and used for further 
experiments. 
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5.2.2.2 GRIP1-CTAP localizes to the membrane of transgenic brain tissue 
 
Stimulation of ephrinB with soluble EphB2 receptor ectodomain causes the formation 
of large raft patches that contain GRIP1 protein (Bruckner et al. 1999). It has 
furthermore been shown that GRIP1 is present in lipid raft fractions isolated from 
mouse (Figure 19c, d) and rat brains (Hering et al. 2003). In fact, two of the binding 
partners that associate with GRIP1, ephrinB and AMPA receptor, have been shown to 
be located in rafts (Dong et al. 1997; Bruckner et al. 1999). To identify complexes, 
which assemble around GRIP1-CTAP and are relevant in ephrinB reverse signaling in 
vivo, we will selectively purify complexes that are associated to the membrane.  
To confirm that the GRIP1-CTAP transgenic mice are suitable for the purification of 
ephrinB-mediated GRIP1 complexes, we next asked if GRIP1-CTAP was properly 
expressed at the membrane in those mice. Therefore, we performed membrane 
fractionation assays and incubated the membrane fractions with different amounts of 
CHAPS or NP-40 for 1h at 4°C. GRIP1-CTAP from membrane fractions was 
precipitated using rabbit IgGs. IgG-pulldowns were subsequently analyzed by SDS-
PAGE and immunoblotted (WB) with PAP-antibody, which specifically detected 
GRIP1-CTAP at approximately 150kDa (Figure 22b). Treatment of membrane 
fractions with NP-40 gave best results as compared to CHAPS. Thus, a proportion of 
GRIP1-CTAP is located as expected at the membrane. 
 
 
_____________________________________________________________________ 
Figure 22. GRIP1-CTAP forms functional complexes in transgenic mice. (a) GRIP1-
CTAP is expressed at high levels in brain of some founder mice. Total brain lysates were 
analyzed by Western blotting with the indicated antibodies. GRIP1-CTAP was detected by a 
peroxidase (POD)-conjugated anti-POD antibody (PAP) or by a specific anti-GRIP1 antibody. 
(b) Brain homogenates from UbiGRIP1-CTAP+/- mice were subjected to a flotation gradient 
membrane fractionation assay, treated for 1 hour with CHAPS or NP-40 at different 
concentrations and analyzed for the presence of GRIP1-CTAP in membranous fractions. Total 
lysates were analyzed by Western blotting for GRIP1-CTAP using the PAP antibody. (c) 
Transgenic GRIP1-CTAP interacts with the known GRIP1-interactor GluR2/3. Membranous 
fractions obtained from transgenic brain homogenates were treated for 1 hour with NP-40 at 
different concentrations and analyzed for the presence of GluR2/3 by immunoprecipitation 
with rabbit IgGs. IgG pulldowns were analyzed by Western blotting with the indicated 
antibodies. (d) GRIP1-CTAP is able to rescue the lethal phenotype of GRIP1-/- mice. Tails 
from different litters were analyzed for the presence of the GRIP1-CTAP transgene and the 
GRIP1 KO allele. 
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5.2.2.3 GRIP1-CTAP interacts in vivo with GluR2/3, a known interactor of 
 GRIP1  
 
AMPA receptor GluR2/3 subunits have been shown to bind to PDZ domain 
containing proteins such as GRIP1 (Dong et al. 1997). This interaction occurs through 
their C-terminal four amino acids (-SVKI), which has been demonstrated to regulate 
AMPA internalization during LTD and to also be possibly involved in the expression 
of LTD in the hippocampus (Kim et al. 2001). To test whether transgenic expression 
of GRIP1-CTAP leads to formation of a properly folded protein in the mouse, we 
performed pulldown studies to analyze the interaction of the exogenous protein with 
the AMPA receptor GluR2/3 subunit as a known interactor of GRIP1. Brain lysates 
from heterozygous, transgenic adult mice, treated with different amounts of NP-40 for 
60 minutes, were incubated with rabbit IgG agarose beads. Western blotting analysis 
of the IgG precipitates with specific antibodies showed that GluR2/3 was co-
precipitated in vivo with GRIP1-CTAP (Figure 22c), consistent with the data obtained 
by Dong (1997). Moreover, GluR2/3 could be detected at highest levels when 
preparing the brain lysate under mild detergent conditions (0.1% NP-40) as shown in 
Figure 22c. Therefore, GRIP1-CTAP is able to interact with its known binding 
partner GluR2/3 in the transgenic mice indicating that it is folded properly. 
 
5.2.2.4 GRIP1-CTAP is able to rescue the lethal phenotype of GRIP-/- mice  
 
GRIP1 mutants die shortly after implantation around E12. Low, but significant, 
numbers of viable GRIP1-/- embryos could be identified up to E16. Elimination of 
murine GRIP1 leads to development of abnormalities of the dermo-epidermal junction 
of GRIP1-/- embryos, resulting in extensive skin blistering around day 12 of 
embryonic life (Bladt et al. 2002). Ultra-structural characterization of the blisters (or 
bullae) revealed cleavage of the dermo-epidermal junction below the lamina densa, an 
alteration reminiscent of the dystrophic form of human epidermolysis bullosa (Bladt et 
al. 2002) and R.L. Huganir, personal communication). In order to confirm that 
GRIP1-CTAP is functional in vivo and is able to form physiologically relevant 
complexes, we have performed a genetic experiment using GRIP1+/- mice, which were 
   5. Results 
 
  70 
crossed with our GRIP1-CTAP transgenic mice. TAP-tagged GRIP1 transgenics when 
crossed to GRIP1+/- mutant mice (kindly provided by R.L. Huganir) give birth to 
GRIP1-/-; GRIP1-CTAPhet litter (Figure 22d). Litter #5 shows amplification of only 
the GRIP1 KO allele, but not the wt allele (top panel) indicating the GRIP1-/- 
genotype. The same litter carries the transgene encoding GRIP1-CTAP as detected by 
PCR (bottom panel). GRIP1-/- mice have never been observed after E16 (Bladt et al. 
2002). Thus, rescuing the lethal embryonic phenotype by crossing in transgenic 
GRIP1-CTAP mice suggests that the GRIP1-CTAP protein is indeed functional in 
vivo and likely to be associated with most of its endogenous binding partners. 
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6. Discussion 
 
6.1 Grb4 and GIT1 transduce ephrinB reverse signals modulating 
 spine  morphogenesis and synapse formation 
 
EphrinB ligands are expressed at synapses in postsynaptic CA1 neurons and have 
been postulated to be the acting signaling partners for EphB receptors regulating 
synaptic plasticity of connections between CA3 and CA1 neurons (Grunwald et al. 
2004). The molecular mechanisms of ephrinB ligand action during synaptic plasticity 
remain unknown. However, morphological changes associated with synaptic plasticity 
might be regulated by ephrinB ligand reverse signaling via the same molecular 
pathways as the formation of new synapses. The work presented in this thesis 
provides evidence for the involvement of ephrinB reverse signaling in spine 
morphogenesis and synapse formation and identifies molecular pathways downstream 
of these ligands in such processes. Activation of the ephrinB ligands in cultured 
hippocampal neurons leads to an increased number of mature spines with mushroom-
like heads, whereas inhibition of reverse signaling by expression of the truncated 
ephrinB1 lacking the cytoplasmic domain renders immature spines and increased 
number of long and thin filopodia. Thus, ephrinB reverse signaling appears to be 
important for spine morphogenesis during development.  
Together, our results point to a signaling complex containing Grb4 and the G-protein-
coupled receptor kinase-interacting protein (GIT)1, which is involved in the 
regulation of spine formation by ephrinB ligands. Our work sheds light onto the 
molecular mechanisms that might underlie ephrinB reverse signaling function in 
important processes involving spine morphogenesis such as synaptic plasticity. 
 
6.1.1 Grb4 and GIT1 transduce signals downstream of ephrinB ligands 
 
Localized changes in the organization and dynamics of the actin cytoskeleton are 
thought to underlie the formation, maintenance, and plasticity of synaptic connections 
(Matus et al. 2000). The Rho family of small GTPases, key regulators of actin 
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dynamics and organization, are pivotal contributor in spinogenesis. Although Eph 
receptor interaction with the Rho pathway is well documented (Noren and Pasquale 
2004), only little is known about how ephrin reverse signaling effects Rho family 
proteins and subsequent signaling to the cytoskeleton. Recent data have shown that 
Dishevelled mediates RhoA and Rho kinase activation downstream of ephrinB1 
(Tanaka et al. 2003). Another link between ephrinBs and RhoA may be 
p190RhoGAP. Mice deficient in p190RhoGAP exhibit a lack of the anterior 
commissure (Brouns et al. 2001), a phenotype associated with a lack of ephrinB 
reverse signaling in EphB2-/- mice (Henkemeyer et al. 1996). Rac, along with the 
other Rho family members RhoA and Cdc42, has an important role in the regulation 
of the actin cytoskeleton in spines (Ramakers 2002). A recent study demonstrates that 
a novel domain in GIT1, the synaptic localization domain (SLD), is required for spine 
morphogenesis and synapse formation (Zhang, H. et al. 2003) by providing a docking 
site for the β-p21-activated protein kinase (PAK)-interacting exchange factor (βPIX), 
which serves as an exchange factor for Rac. This observation has been extended now 
by identifying a signaling pathway downstream of Rac, including PAK and myosin II 
regulatory light chain (MLC) and involved in the regulation of spine morphogenesis 
and synapse formation (Zhang, H. et al. 2005). Therefore, GIT1 appears to organize a 
signaling module containing an activator and effector of Rac that localizes and 
regulates Rac activity in dendritic spines and synapses. A mislocalized hyperactive 
signaling complex leads to an overabundance of dendritic protrusions, whereas a loss-
of-function mutation leads to decreased spine density (Zhang, H. et al. 2005). 
However, the signaling pathway or molecule that targets GIT1 and the entire signaling 
module to synapses and thereby induces spine formation and synaptogenesis remained 
so far unknown. 
The findings presented here implicate the SH2/SH3-domain containing adaptor Grb4, 
GIT1 and βPIX as important components of the signaling apparatus downstream of 
ephrinB ligands. The co-expression studies in PSDs of hippocampal neurons together 
with previously published data (Grunwald et al. 2004) support the idea that Grb4, 
GIT1, βPIX and ephrinB ligands act in concert in regulating spine morphogenesis and 
synapse formation. As we have shown, GIT1 is targeted to membrane patches at 
synapses of hippocampal neurons after ephrinB activation and interacts with ephrinB1 
and Grb4 in mouse brain. Moreover, we have shown that dominant negative 
interfering with the binding of Grb4 to ephrinB ligands (using the ephrinB1-313-335 
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peptide) and with GIT1 to Grb4 (using Grb4-SH2) impaired spine morphogenesis and 
synapse formation in dissociated rat hippocampal neurons mimicking the phenotype 
obtained previously when disrupting synaptic targeting of GIT1 by overexpression of 
the SLD domain (Zhang, H. et al. 2003). This suggests that overexpression of any of 
these dominant-negative molecules impairs the recruitment of endogenous Grb4-
GIT1-PIX-Rac complex to ephrinB1 ligands at the synapse. The findings of the 
presented study therefore implicate that the molecular mechanism leading to GIT1-
PIX-Rac-PAK-mediated spine formation and maintenance involves activated ephrinB 
ligand, its downstream interactor Grb4 and GIT1 indicating that ephrinB ligand 
provides the docking site for GIT1 and activated Rac to the synaptic membrane.  
 
6.1.2 Are GIT proteins general downstream effectors of Grb4/Nck signaling? 
 
We postulate that Grb4 serves to bridge ephrinB ligands with GIT1 at synapses. 
Consistent with this, we can show that the domain in GIT1 required for binding to 
Grb4 is indeed the SLD domain, a 221 aa stretch that has been shown to be required 
and sufficient for the synaptic localization of GIT1 (Zhang, H. et al. 2003). Mutant 
GIT1 lacking the NH2-terminal 32 aa of the SLD has been shown to localize to 
synapses significantly less (Zhang, H. et al. 2003) suggesting that these 32 aa 
contribute to efficient synaptic localization of GIT1. Interestingly, we show that 
Tyr392 in GIT1, which is present in the NH2-terminal 32 aa of GIT1 SLD, is required 
for GIT1 binding to the Grb4 SH2 domain. Moreover, Tyr392 is located in a sequence 
(YDSV) conserved among the GIT family and it resembles the consensus sequence 
for Nckα SH2 binding (Songyang et al. 1993).  
Using the ephrinB1 ligand ectodomain, we have also been able to co-precipitate GIT 
proteins with EphB receptors from adult mouse brain suggesting that GIT proteins 
could also act downstream of the receptor. Nckα binds exclusively to the receptor 
(Stein et al. 1998). Thus, a Nckα-GIT complex could be transducing the signals 
downstream of the receptor, while the Grb4-GIT complex may be restricted to 
signaling events downstream of the ligand. Grb4 is involved in transducing reverse 
signals into ephrinB-expressing cells (Cowan and Henkemeyer 2001) most likely 
regulating the cytoskeleton. Half of the known SH3 domain binding partners of the 
Nck proteins (Grb4 and its closest relative Nckα) have direct or indirect roles in the 
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regulation of actin dynamics (Li et al. 2001). Among them, a number regulate the 
activity of the Rho family of small GTPases. These include the exchange factors for 
Rac, Dock180 (dedicator of cytokinesis 180) and hnRNP K (heterogeneous nuclear 
ribonucleoprotein K), and PAK1, which regulates both Rac and Rho. Among the Nck-
SH3-effector complexes, the Nckα-PAK1-PIX-GITI complex is so far the best 
studied. Nckα relocates PAK1-PIX to the membrane proximity (Zhao et al. 2000a). 
The PAK1-associated PIX activates Rac (Obermeier et al. 1998) and binds to GIT1 
and focal adhesion kinase (FAK) thereby promoting cell motility by regulating focal 
complex dynamics (Zhao et al. 2000b). Thus, as Nck has been shown to bind to GIT 
proteins in a number of different scenarios (Zhao et al. 2000a; Brown, M. C. et al. 
2005), these proteins might very well be general downstream effectors of Grb4/Nck 
proteins in different biological processes. 
 
6.1.3 Regulated Grb4-GIT1 interaction during phosphotyrosine-dependent 
 ephrinB reverse signaling 
 
In cells stably expressing physiological levels of ephrinB1, phosphorylation of Tyr392 
and consequent interaction between endogenous GIT1 and Grb4 via its SH2 domain is 
not constitutive, but rather induced by EphB2 receptor engagement. The kinase 
required for phosphorylation of GIT1 on Tyr392 is unidentified. However, it is known 
that Src family kinases (SFKs) are rapidly recruited to ephrinB expression domains 
upon EphB receptor engagement, and this transient activation positively regulates 
ephrinB phosphorylation and phosphotyrosine-mediated reverse signaling (Palmer et 
al. 2002). The kinetics of ephrinB-mediated SLD phosphorylation correlate very well 
with the previously reported kinetics of Src recruitment to, and activation in 
ephrinB/EphB-containing membrane patches. Therefore, activation of the ephrinB 
ligand could recruit Src to PSDs, where ephrinB has been located (Grunwald et al. 
2004), to specifically phosphorylate GIT1 at synapses. Interestingly, GIT1 has already 
been shown to be phosphorylated on tyrosine residues by c-Src in response to 
angiotensin II and epidermal growth factor in vascular endothelial cells and 293 cells 
(Haendeler et al. 2003), and in response to thrombin in HUVECs (van Nieuw 
Amerongen et al. 2004). GIT2, a family member homologous to GIT1, has been 
demonstrated to be phosphorylated at Tyr392 by Src and FAK (Brown, M. C. et al. 
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2005). GIT proteins might therefore be general substrates for SFKs downstream of 
different receptors.  
 
6.1.4 SH3 domains contribute to Grb4 interaction with ephrinB ligand  
 
Grb4 was identified as an ephrinB1 binding partner in a modified yeast two-hybrid 
screen, which allows for the detection of protein−protein interactions involving 
phosphotyrosine (Cowan and Henkemeyer 2001). The Grb4 SH2 domain was shown 
to associate with the cytoplasmic domain of tyrosine-phosphorylated ephrinB ligands 
in an Eph receptor stimulation-dependent fashion. We now identified the same 
domain in Grb4 to be crucial for association with phosphorylated GIT1. However, 
how can Grb4 be the bridging molecule in an ephrinB-Grb4-GIT1 complex and bind 
to ephrinB1 and to GIT1 at the same time via its SH2 domain? We have shown that 
Grb4 is not only able to bind to ephrinB ligands though its SH2 domain but it also 
binds through the SH3 domains. We postulate that Grb4 binding to ephrinB ligands is 
regulated by Eph receptor stimulation but is not exclusively phosphotyrosine-
dependent. In agreement with this hypothesis we observe long lasting co-localization 
of Grb4 with ephrinB patches (Manuel Zimmer and Amparo Acker-Palmer, 
unpublished results), even after ephrinB ligands have undergone dephosphorylation 
by the phosphatase PTP-BL, which typically occurs 15 minutes after stimulation 
(Palmer et al. 2002). Moreover, a mutant of ephrinB1, which has all 6 tyrosines 
present in the intracellular domain mutated to phenylalanine, was still able to bind to 
Grb4 (Manuel Zimmer and Amparo Acker-Palmer, unpublished results). The 
assembly of the triple complex formed by ephrinB-Grb4-GIT1 might therefore occur 
in different scenarios: (1) the interaction of Grb4 with ephrinB might be initiated by 
phosphotyrosine-dependent association of the Grb4 SH2 domain with phosphorylated 
ephrinB ligands and later stabilized by the Grb4 SH3 domains. The stabilization 
would in turn release the Grb4 SH2 domain and make it available for interaction with 
GIT1. Consistent with this, a characteristic PXXP motif for binding SH3 domain 
proteins is present in ephrinB cytoplasmic tails close to the PDZ binding motif. (2) 
The formation of a Grb4 dimer through association of the SH3 domains may enable 
the interaction with ephrinB and GIT1 at the same time via the two available SH2 
domains. (3) Alternatively, Grb4 may also be present in the cell in two different 
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populations, one that interacts with ephrinBs via the Grb4 SH3 domains and binds to 
GIT1 through the free Grb4 SH2 domain, and another, which does not assemble with 
GIT1 and interacts with ephrinBs via the Grb4 SH2 domain to exert different 
functions. 
 
6.1.5 EphrinB reverse signaling and mental retardation 
 
Pathological changes in dendritic spines are often observed in brain disorders such as 
nonsyndromic mental retardation (MR) (Fiala et al. 2002). As the importance of spine 
morphogenesis in cognitive function has become clearer, there has been accelerating 
interest in understanding its molecular basis. Through means of positional cloning, 13 
genes associated with nonsyndromic MR have been identified to date and three of 
these genes encode for regulators of Rho GTPases (Allen et al. 1998; Billuart et al. 
1998; Kutsche et al. 2000; Barnes and Milgram 2002; Ramakers 2002). However, the 
mechanisms by which these mutations lead to cognitive defects are not understood. 
One possibility is that decreased neuronal connectivity results from aberrant actin 
organization (Marin-Padilla 1972; Huttenlocher 1974; Purpura 1974; Kaufmann and 
Moser 2000). Indeed, some children with nonsyndromic MR show abnormalities in 
dendritic spine morphology in their cerebral cortex, i.e., numerous very long and thin 
spines and a reduction in the number of stubby and mushroom-shaped spines (Purpura 
1974). In the present study, the dominant-negative molecules disrupting the 
interaction ephrinB-Grb4 and Grb4-GIT1 show an intriguingly similar dendritic spine 
phenotype in cultured neurons. These mutant constructs also cause a decrease in 
synaptic density. Thus, our results suggest a scenario in which aberrant Rho family 
signaling could lead to decreased neuronal connectivity and eventually impaired 
cognitive functions. Interestingly, PAK3, one of the human MR mutations linked to 
Rho, has been identified in the signaling module downstream of GIT1 (Zhang, H. et 
al. 2005) and might therefore be mislocalized upon disruption of the ephrinB-Grb4-
GIT1 complex. Another gene associated with nonsyndromic MR is αPIX, a close 
relative of βPIX, which was as well identified as a novel Grb4 interactor in our 
proteomic approach. 
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6.2 Proteomic analysis of PDZ-mediated ephrinB reverse signaling 
 
The cytoplasmic tail of ephrinB ligands contains a PDZ binding motif, which is 
important for reverse signaling. Some multi-PDZ-domain-containing proteins have 
been shown to bind to the carboxy-terminal (YKV) target site of ephrinB ligands. 
Previous work proposed the presence of a switch mechanism, which allows a shift 
from phosphotyrosine-dependent to PDZ-domain-dependent signaling (Palmer et al. 
2002). Work presented in this thesis has been designed to dissect the nature of protein 
complexes that are involved in the PDZ-dependent signaling downstream of ephrinB 
ligands. As a target we have chosen the glutamate receptor interacting protein GRIP1, 
a 7 PDZ-domain containing protein that was shown to be specifically recruited into 
rafts through association with the cytoplasmic domain of ephrinB (Bruckner et al. 
1999). The binding of GRIP1 to the cytoplasmic tail of ephrinB ligands appears to be 
regulated by Eph receptor binding (Manuel Zimmer, personal communication). 
Besides our findings for GRIP1, I will also discuss the proteomics data mentioned in 
chapter 5.1.3, which we obtained for the phosphotyrosine-dependent ephrinB 
interactor Grb4. The functional and biological relevance of novel Grb4 interactions in 
ephrinB reverse signaling is discussed in detail in chapter 6.1 (“Grb4 and GIT1 
transduce ephrinB reverse signals modulating spine morphogenesis and synapse 
formation”). 
 
6.2.1 Identification of Grb4 and GRIP1 complexes by tandem affinity 
 purification 
 
Using affinity purification of the two TAP-tagged ephrinB ligand-interactors Grb4 and 
GRIP1 from neuroblastoma cell lysates in combination with mass spectrometry, we 
could isolate a number of potential Grb4 (17) (Table 1) and GRIP1 (61) (Table 2) 
interactors. Conspicuous targets of Grb4 and GRIP1, mainly cytoskeleton-related 
proteins such as tubulin, actin, tropomyosin, myosin alkali light chain, but also heat 
shock proteins or proteins like Elongation factor 1 alpha 1 (which has been shown to 
bind to a number of cytoskeleton-related proteins (Gross and Kinzy 2005)), were 
removed from consideration by consulting a dataset of “potentially sticky proteins” 
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that has been provided by Cellzome, even though some of these proteins might be 
genuine binding partners of these proteins.   
The pre-selected lists (without “potentially sticky proteins”) of Grb4- and GRIP1-
interactors however did not contain any of the published interactors of the two 
proteins, likely because their expression levels were low or these interactions might be 
cell type-specific and not be present in the neuroblastoma cell line used.  
Some of the newly identified binders have already been linked directly or indirectly to 
the regulation of the cytoskeleton, e.g. GIT1, GIT2, αPIX, βPIX or neurabin II 
(Brown, M. C. et al. 2005; Filipenko et al. 2005; Tsukada et al. 2005), and could 
therefore be potentially involved in ephrinB reverse signaling to the cytoskeleton. For 
other interactors, it is more difficult to determine whether they are really part of a 
Grb4/GRIP1 cytoskeleton remodeling complex. Some of the proteins involved in 
Grb4 and GRIP1 complexes, e.g. hnRNP A2/B1 or growth-arrest-specific protein 1, 
are likely to have additional cellular functions not related to cytoskeleton remodeling, 
and some of these interactors may reflect such functions. Among those remaining 
proteins that were co-purified are some whose known function may suggest a possible 
role in membrane trafficking. For example, the depletion of the GRIP1-interactor 
ADP-ribosylation factor 4 (ARF4) causes defects in secretory and endocytic traffic 
(Volpicelli-Daley et al. 2005).  
So far, most systematic protein-protein interaction studies and protein networks have 
relied on yeast two-hybrid techniques (Drewes and Bouwmeester 2003). Compared 
with these approaches, affinity purification of complexes coupled to mass 
spectrometry-based protein identification offers the advantage of studying actual 
molecular assemblies made up by direct and cooperative interactions. Moreover this 
approach allows purification from human cells, different types of tissue (for example, 
from the UbiGRIP1-TAP mouse), or even subcellular compartments (e.g. membrane, 
PSDs) under close to physiological conditions, rather than relying on reconstituted 
bimolecular interactions ex vivo (Gavin et al. 2002). Finally, the introduction of a dual 
purification strategy, TAP-tagging, represents a major improvement in sample 
purification for mass spectrometry. Compared to single purification steps, the double 
purification gives a much better purity yield resulting in a better specificity of binding 
partners. Due to the high degree of specificity conferred by the tandem purification, 
stringent washes are not necessary, allowing better preservation of less stable 
multiprotein complexes The number and quantity of contaminating proteins is also 
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low. The strength of the dual purification strategy, as compared with a single 
purification step with either tag alone, has also been demonstrated in the original 
publication of the TAP strategy (Rigaut et al. 1999).  
In summary, my interaction proteomics approach has provided a list of Grb4 and 
GRIP1 protein complexes demonstrating an expected correlation with cytoskeleton 
remodeling. We have identified a number of novel interactors, some of which have 
previously been demonstrated to form complexes with each other. The data provided 
in this study should provide a point of departure for more in depth studies that will 
eventually lead to a more complete description of events occurring downstream of 
Grb4 and GRIP1, some of them in ephrinB reverse signaling. 
From our list, we decided to continue characterizing in more detail two interactions: 
between GRIP1 and 14-3-3 and between Grb4 and GIT1. Four potential interactors of 
Grb4 have been identified: GIT1 (Cat1), GIT2 (Cat2), αPIX (RhoGEF6, Cool-2) and 
βPIX (RhoGEF7, Cool-1) (Table 1). Each of these has been reported previously to 
associate with the others (Bagrodia et al. 1999). The interaction Grb4-GIT1 was 
subject of the first part of my thesis. The interaction between GRIP1 and 14-3-3, 
which was additionally verified by reverse tandem affinity purification (Cellzome, 
personal communication) will be discussed below. 
 
6.2.1.1 Identification of 14-3-3 as a GRIP1 binding protein 
 
Signaling pathways regulate the dynamics of cell behavior by directing the assembly 
of multicomponent complexes (Hubbard and Cohen 1993; Pawson and Scott 1997; 
Pawson and Nash 2003). How can this be achieved within the crowded environment 
of a cell? The emerging answer is that many proteins have modular structures and 
contain distinct adapter domains that are specialized for binding to the most prevalent 
means of posttranslational modification, which is protein phosphorylation. 
Interestingly, many aspects of dynamic cellular behavior are regulated by reversible 
protein phosphorylation (Hunter 2000). Protein kinases frequently exert their 
biological effects by creating docking sites for adaptor domains, which selectively 
recognize phosphorylated motifs in their binding partners (Pawson and Nash 2003). 
14-3-3 proteins for example bind to serine/threonine-phosphorylated residues in a 
context-specific manner, analogous to the Src homology 2 (SH2) and phosphotyrosine 
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binding (PTB) domains, which associate with tyrosine-phosphorylated residues. 
Interestingly, it has been shown that GRIP1 may be phosphorylated on 
serine/threonine residues by an unknown serine/threonine kinase that associates with a 
complex formed by ephrinB and GRIP1 (Bruckner et al. 1999). Our observations 
show that association between GRIP1 and 14-3-3 occurs via a conserved 14-3-3 
binding site in the C-terminus of GRIP1. Furthermore, 14-3-3, GRIP1 and ephrinB1 
ligand interact exclusively in rafts of mouse brain supporting their signaling function 
in vivo and indicating that the GRIP1-14-3-3 complex may have an important function 
in organizing a signaling complex for ephrinB reverse signal transduction.  
 
6.2.1.2 GRIP1 contains three putative 14-3-3 binding sites, but only one is 
 required for interaction 
 
14-3-3 proteins were the first polypeptides shown to have phosphothreonine/serine 
(pSer/Thr) binding properties (Muslin et al. 1996). Structural analysis has shown that 
each 14-3-3 protomer folds into an α-helical structure with a conserved binding 
groove that accommodates pSer/Thr-binding sites (Yaffe et al. 1997; Obsil et al. 
2001), typically generated by basophilic kinases such as cAMP-dependent protein 
kinase (PKA) and protein kinase B (PKB) (Fu et al. 2000; Yaffe 2002). Accordingly, 
two optimal 14-3-3 phosphopeptide ligands with the consensus sequences RSXpSXP 
(mode I) and RXY/FXpSXP (mode II), where X is any amino acid, have been defined 
with degenerated peptide libraries (Muslin et al. 1996; Yaffe et al. 1997). Although 
we identified three putative 14-3-3 binding sites inside the linker region between 
PDZ6 and PDZ7 of GRIP1, which all exactly match the optimal sequence motif of 
mode I, mutation analysis showed only one of them to be required for 14-3-3 binding 
to GRIP1. Interestingly, the identified motif (RSNTLP) encompassing threonine 956 
is the only one out of all three, which is specific for GRIP1 and therefore not 
conserved in GRIP1-homolog GRIP2. Indeed, preliminary data indicate that 14-3-3 
interaction is exclusively restricted to GRIP1 (Inmaculada Segura, personal 
communication). However, previous studies have shown that GRIP1 may be able to 
form homomultimers or heteromultimers with GRIP2, allowing the formation of very 
large macromolecular complexes that might also include 14-3-3, which is recruited by 
GRIP1 (Dong et al. 1999).  
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6.2.1.3 What is the functional relevance of Thr956 in vivo? 
 
Setou and colleagues (Setou et al. 2002) have previously shown that GRIP1 can 
directly interact with kinesin and mapped the kinesin-binding domain in GRIP1 to the 
linker region between PDZ6 and PDZ7 (753-987, termed L2), which also contains the 
14-3-3 recognition motif we identified. Kinesin heavy chain (also known as KIF5) 
knockout and dominant-negative experiments showed an abnormal perinuclear 
clustering of GRIP, and overexpression of the KIF5-binding domain of GRIP in 
neurons resulted in an accumulation of kinesin in dendrites. Therefore, it has been 
postulated that GRIP “steers” kinesin transport into dendrites, thereby sorting specific 
protein complexes to dendritic structures (for example, AMPA receptors) (Setou et al. 
2002). Moreover, Hoogenraad and co-workers recently demonstrated a molecular 
mechanism in which KIF5-dependent trafficking of a GRIP1/EphB receptor complex 
is critical for dendrite morphogenesis (Hoogenraad et al. 2005). However, the exact 
site within L2 of GRIP1, which is necessary for GRIP1-KIF5 interaction, has not been 
mapped and thus it remains for future studies to test the role of Thr956 in GRIP1 in 
this interaction and whether this residue is functionally relevant in vivo. Interestingly, 
a mutant of GRIP1, in which Thr956 is replaced by Ala and therefore cannot bind to 
14-3-3 any longer, disrupts the formation and growth of dendrites in hippocampal 
neurons (Inmaculada Segura, personal communication). These data suggest that 14-3-
3 could bridge GRIP1 and KIF5 together in a phosphorylation-dependent manner to 
anchor these two proteins within close proximity of one another. Interestingly, KIF5B 
has been shown to be a target of 14-3-3 protein as well (Ichimura et al. 2002). 
 
6.2.1.4 Which is the kinase required for phosphorylation of Thr956 in GRIP1? 
 
GRIP1 is associated with a serine/threonine kinase activity when forming a complex 
with ephrinB ligands (Bruckner et al. 1999). This kinase might phosphorylate serines 
or threonines in GRIP1 upon ephrin activation, creating docking sites for 14-3-3 
molecules. Support for this idea comes from an observation by Amparo Acker-Palmer 
(personal communication), which shows that only the C-terminal half that contains 
the identified 14-3-3 binding site, but not the N-terminal half of GRIP1, becomes 
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phosphorylated after Eph receptor stimulation. A potential kinase that regulates the 
phosphorylation state of GRIP1 in ephrinB reverse signaling, might be the protein 
kinase Cdc25C-associated kinase 1 (C-TAK1), which has been co-purified with 
GRIP1 in a TAP approach using 14-3-3-eta- and -zeta-TAP (Cellzome, personal 
communication). C-TAK1 is a member of the EMK/MARK/Par1 kinase family and 
was first cloned based on its ability to associate with and phosphorylate Cdc25C (Ogg 
et al. 1994; Peng et al. 1998). Subsequently, the tyrosine phosphatase PTPH1 and 
KSR1 were found to be phosphorylated by C-TAK1 (Zhang, S. H. et al. 1997; Muller 
et al. 2001). Strikingly, for all known substrates of C-TAK1 (KSR1, Cdc25C and 
PTPH1), the residue phosphorylated by C-TAK1 serves as a 14-3-3 binding site. 
However, the exact identity of the kinase and its relevance in GRIP1 phosphorylation 
in response to Eph/ephrin signaling will have to be further explored. So far, the 
presented data only indicate the requirement of Thr956 for GRIP1 binding to 14-3-3. 
It would be of great interest to test if Thr956 is a major phosphorylation site in vivo 
and whether phosphorylation of this residue indeed directly increases the affinity of 
GRIP1 to 14-3-3. 
 
6.2.1.5 GRIP1 interaction with 14-3-3 and raft microdomains 
 
Previous work has shown that ephrinB ligands and SFKs, positive regulators of 
ephrinB phosphorylation, are both located in lipid rafts, and stimulation with soluble 
EphB receptor leads to reorganization of ephrinB- and Src-containing rafts into larger 
membrane patches (Palmer et al. 2002). Additionally, GRIP1 co-localizes with 
ephrinB1 raft patches (Bruckner et al. 1999). These specialized membrane 
microdomains are proposed to serve as sites of signal integration of signaling in a 
wide variety of processes (e.g. signal transduction), based on the many molecules 
known to be involved in intracellular signaling, which are enriched in this fraction 
(Simons and Toomre 2000; Zajchowski and Robbins 2002).  
Strikingly, the interaction of 14-3-3 with GRIP1 was found to be restricted to raft 
microdomains in mouse brain, indicating that both molecules associate with each 
other only upon an external stimulus, which then recruits the complex to these 
signaling centers. Furthermore, a small but significant and isoform-selective 
proportion of the 14-3-3 in mouse brain was raft associated, suggesting that this 14-3-
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3 might acquire new or enhanced functions on association with GRIP1 in raft 
microdomains. Although only a small proportion of the total brain 14-3-3 localizes to 
rafts, the association of it with only a specific subset of membranes suggests that it is 
functionally important. Similarly, Martin and co-workers have found that some of the 
14-3-3 in rat brain is selectively associated with some synaptic membranes raising the 
possibility that their presence in synapses might indicate a role in controlling 
phosphorylation of synaptic proteins (Martin et al. 1994). Our finding that ephrinB 
ligand interacts with GRIP1 and 14-3-3 in rafts support the hypothesis of ephrinB 
ligands signaling from highly organized signaling centers such as raft microdomains. 
Assembly of this signaling complex may be induced by EphB2 receptor binding to 
ephrinB1 (Manuel Zimmer, personal communication). Whether the interaction 
between GRIP1 and 14-3-3 is actually regulated by EphB receptor engagement of the 
ligand still needs to be investigated. 
 
6.2.2 Transgenic expression of GRIP1 in mice to identify protein complexes in 
 vivo 
 
Because of its multi PDZ-domain structure GRIP1 is likely to interact with other 
cytoplasmic proteins. One of these proteins is the ras-GTP-exchange factor GRASP-1 
(GRIP-associated protein 1) (Ye et al. 2000), however many others have been 
described as well, such as GluR2, EphB receptor, liprin-alpha, Fras1, PICK1 and 
NEEP21 (Dong et al. 1997; Torres et al. 1998; Wyszynski et al. 2002; Takamiya et al. 
2004; Lu, W. and Ziff 2005; Steiner et al. 2005). Together the available data suggests 
that GRIP1 molecules could serve as scaffolds for large protein complexes involved 
in signaling at the plasma membrane. To identify the complete “GRIP-signaling-
complex” we also applied the TAP tag technology in vivo by expressing TAP-tagged 
GRIP1 in transgenic mice using an ubiquitous promoter. This approach has several 
advantages over other methods for identification of protein-protein interactions: (a) 
the use of an in vivo model; (b) the purification of a protein complex that has been 
established in its natural environment, and (c) the comparison of GRIP1-protein 
complexes derived from different tissues/subcellular compartments (e.g. rafts or 
synaptic membranes).  
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6.2.2.1 Transgenic GRIP1-CTAP protein is functional 
 
Transgenic GRIP1-CTAP mice did not show any overt abnormalities, and several 
founders were tested for GRIP1-CTAP protein expression. The founders expressed 
varying levels of GRIP1-TAP, but in general the expression was moderate, possibly 
not more that 2-3 fold above endogenous levels. GRIP1-CTAP purified by tandem 
affinity purification associates in membrane fractions with its known interaction 
partner GluR2/3 providing further evidence for GRIP1-CTAP assembling with 
functional and physiologically relevant protein complexes. In order to confirm that the 
TAP-tagged protein is functional in vivo, we performed a genetic experiment with the 
GRIP1-CTAP transgenic mice. TAP-tagged GRIP1 transgenics when crossed with 
GRIP1-/- mutant mice (provided by R.L. Huganir) rescued the lethal phenotype of this 
null mutation, indicating that the GRIP1-CTAP protein is functional in vivo and likely 
to be associated with its endogenous binding partners. Therefore, these mice could 
also serve in the future as a tool for the verification of in vivo interactions with the 
candidates obtained in a first round of purification with the neuroblastoma cell line 
stably expressing GRIP1-CTAP. Moreover, since the transgene rescues the lethal 
phenotype of the GRIP1 KO, we could also use the transgenic mice as a genetic tool 
to try to identify regions in the GRIP1 protein and interactions with other proteins 
required for its in vivo function. 
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6.3 Concluding remarks 
 
Our studies reveal a new function of ephrinB reverse signaling in spine 
morphogenesis and synapse formation, which might be related to the known 
functional relevance of reverse signaling in synaptic plasticity (Grunwald et al. 2004). 
The pathway downstream of the ligand, which we demonstrated to be required for this 
function, involves the SH2-SH3 adaptor Grb4 and the scaffolding protein GIT1. 
Interestingly, GIT1 has been very recently shown to form a signaling complex with 
PIX, Rac, and PAK playing an essential role in the regulation of dendritic spine and 
synapse formation through modulating MLC activity (Zhang, H. et al. 2005). Thus, 
the ephrinB signaling pathway could serve as the upstream signaling cascade leading 
to the regulated formation and localization of this complex. 
The analysis of ephrinB1/2/3 triple mutant mice is in progress and will help to 
elucidate the function of the ephrinB ligands in the context of spine development in an 
intact hippocampus. However, the lack of ephrinB ligands in these mice may lead to a 
decreased activation of EphB forward signaling and, therefore, abnormal spine 
development might be at least to some extent caused by disruption of signaling 
pathways downstream of the receptor. 
A number of issues remain unanswered. For instance, are effects of CA3-CA1 long-
term plasticity mediated by similar signaling mechanisms as in spine formation? What 
role does internalization of the Eph/ephrinB complex, a process that was recently 
shown to regulate the cellular response to Eph/ephrin signaling (Marston et al. 2003; 
Zimmer et al. 2003), have at the synapse? Is the novel Grb4 interactor αPIX, 
mutations of which have been found in patients with nonsyndromic mental 
retardation, involved in ephrinB-mediated spinogenesis as well? And does the switch 
from phosphorylation- to PDZ-dependent ephrinB reverse signaling, as suggested by 
Palmer and colleagues (Palmer et al. 2002), play a role in synapse formation? This 
could be relevant for multi-PDZ protein GRIP1-mediated AMPA receptor targeting 
and organization of postsynaptic complexes, which, interestingly, seems to also 
require GIT1 (Wyszynski et al. 2002; Ko et al. 2003). These issues could be addressed 
in future studies using the tools and observations described in this thesis.   
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7. Materials and Methods 
 
7.1 Materials 
 
7.1.1 Buffers and solutions 
 
7.1.1.1 Media and antibiotics for bacterial culture 
 
LB (Luria-Bertani-) media   10 g Bacto-Trypton 
      5 g Yeast extract 
      5 g NaCl 
      add H2O to 1 l, adjust pH to 7.5 
LB plates     supplement with 15 g/l agar 
 
Antibiotics     diluted 1:1000 
Ampicillin     Stock 100 mg/ml in H2O 
Kanamycinsulfate    Stock 50 mg/l in H2O 
 
7.1.1.2 Media and supplements for tissue culture 
 
DMEM Dulbecco’s Modified Eagle medium 
DMEM FBS G418 DMEM, 10% Foetal bovine serum, 0.292 mg/ml L-
Glutamine, 100 U/ml Penicillin, 100 µg/ml 
Streptomycin, 350 µg/ml geneticin sulfate (G418). 
Neurobasal, 2% B27 neurobasal medium (Invitrogen) was supplemented with 
B27 supplement (Invitrogen)  
OptiMEM GlutaMAX, 
5% Iron suppl. CS 
Optimem medium (Invitrogen) was supplemented with 
Iron suppl. Calf Serum (Sigma) 
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7.1.1.3 Media and supplements for primary culture of neurons 
 
Borate Buffer (500 ml) 1.24 g boric acid, 1.9 g Borax ad 400 ml H2O (pH 8.5) 
HBSS 135 mM NaCl2, 20 mM Hepes, 4 mM KCl, 1 mM 
Na2HPO4, 2 mM CaCl2, 1 mM MgCl2, 10 mM glucose 
(pH 7.3) 
 
7.1.1.4 Solutions for Biochemistry 
 
Laemmli stacking gel 4% w/v acrylamid/bis 29:1 
130 mM Tris-HCl (pH 6.8), 
0.4% SDS 
0.1% APS 
0.1% TEMED 
10% Laemmli separating gel 10% w/v acrylamid/bis 25:1 
130 mM Tris-HCl (pH 8.8),  
0.4% SDS 
0.05% APS 
0.05%TEMED 
5x Laemmli electrophoresis buffer  130 mM Tris base 
960 mM Glycine 
17 mM SDS 
10x Transfer buffer (2.5 l) 200 mM Tris base 
1.5 M Glycine 
34 mM SDS 
Stripping buffer 5 mM sodium phosphate buffer (pH 7.25) 
2 mM β-mercaptoethanol 
2% SDS 
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6x Sample buffer for reducing 
conditions 
42 mM SDS 
300 mM Tris-HCl (pH 6.8) 
600 mM DTT 
52% Glycerol 
Bromophenol blue 
50 mM Tris-HCl (pH 7.5) 
0.15 mM NaCl 
0.5-1% Triton X-100 
Add fresh: 
Lysis buffer, 0.5-1% Triton X-100 
1 mM Na3VO4 
10 mM NaPPi 
20 mM NaF 
Protease inhibitor cocktail tablet (complete) 
(1 tablet/50 ml) 
50 mM Hepes (pH 7.5) 
150 mM NaCl 
10% Glycerol 
0.1% Triton X-100 
1.5 mM MgCl2 
1 mM EGTA 
Add fresh: 
PLC lysis buffer 
1 mM Na3VO4 
10 mM NaPPi 
20 mM NaF 
Protease inhibitor cocktail tablet (complete) 
(1 tablet/50 ml) 
20 mM Hepes (pH 7.5) 
150 mM NaCl 
10% Glycerol 
0.1% Triton X-100 
Add fresh: 
HNTG buffer (100 ml) 
1 mM Na3VO4 
Protease inhibitor cocktail tablet (complete) 
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 (1 tablet/50 ml) 
Lysis buffer (TAP) 50 mM Tris-HCl (pH 7.5) 
5% Glycerol 
0.2% NP-40 
1.5 mM MgCl2 
1 mM DTT 
100 mM NaCl 
Add fresh: 
50 mM NaF 
1 mM Na3VO4 
2 μM microcystine-LR 
Protease inhibitor cocktail tablet (complete), 
EDTA-free (1 tablet/50 ml) 
TEV Cleavage buffer (TAP) 10 mM Tris-HCl (pH 7.5) 
100 mM NaCl 
0.1% NP-40 
0.5 mM EDTA 
1 mM DTT 
CBP washing buffer (TAP) 10 mM Tris-HCl, (pH 7.5) 
100 mM NaCl 
0.1% NP-40 
1 mM Mg(CH3COOH)2 
1 mM Imidazole 
2 mM CaCl2 
1 mM DTT 
2x CBP dilution buffer (TAP) 10 mM Tris-HCl (pH 7.5) 
100 mM NaCl 
0.1% NP-40 
2 mM MgAc 
2 mM Imidazole 
4 mM CaCl2 
1 mM DTT 
CBP elution buffer (TAP) 10 mM Tris-HCl (pH 8.0) 
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5 mM EGTA 
Solution A (PSD purification) 0.32 M sucrose  
20 mM HEPES (pH 7.4)  
Add fresh: 
50 mM NaF 
1 mM Na3VO4 
1 mM PMSF  
Protease inhibitor cocktail tablet (complete) 
(1 tablet/50 ml) 
Solution B (PSD purification) 0.32 M sucrose  
20 mM HEPES (pH 7.4)  
Solution C (PSD purification) 12 mM Tris (pH 8.0) 
1% Triton X-100 
Solution D (PSD purification) 40 mM Tris (pH 8.0) 
Solution E (PSD purification) 12 mM Tris (pH 8.0)  
6% sarcosyl (N-lauryl-sarcosine) 
Tail lysis buffer  50 mM KCl  
1.5 mM MgCl2  
10 mM Tris (pH 7.5/8.5)  
0.45% NP-40  
0.45% Tween20 
TNE buffer 25 mM Tris-HCl (pH 7.5)  
150 mM NaCl  
0.8 mM EDTA, 250 mM sucrose 
Add fresh: 
50 mM NaF 
1 mM Na3VO4 
2 μM microcystine-LR 
Protease inhibitor cocktail tablet (complete) 
(1 tablet/50 ml) 
 
7. Materials and Methods 
91 
7.1.2 Bacteria 
 
TOP10 
 
F- mcrA D(mrr-hsdRMS-mcrBC) F80 lacZ DM15 DlacX74 recA1 
araD139 D(ara-leu7697) galU galK rpsL (Strr) endA1 nupG 
DH5α 
 
supE44 DlacU169 (F80 lacZ DM15) hsdR17 recA1 endA1 gyrA96 
thi-1 relA1 
 
7.1.3 Plasmids 
 
7.1.3.1 GIT1 expression constructs 
 
Expression construct encoding full-length rat GIT1-Flag was a gift from R.T. Premont 
and is described (Premont et al. 1998). To generate GIT1ΔSLD-Flag, two restriction 
sites were inserted by mutagenesis into GIT1-Flag. Point-mutated rat GIT1-Flag was 
generated by site directed mutagenesis leading to exchange of Tyr392 to Phe. To 
generate SLD-YFP, the SLD coding region (384-596) was cloned into pEYFP-N1 
(Clontech) using XhoI and XmaI restriction sites. An expression construct encoding 
SLD-V5 was generated using the Gateway site-specific recombination system 
(Invitrogen) to insert SLD into pcDNA3.2/V5-DEST (Invitrogen). 
 
7.1.3.2 Grb4 expression constructs 
 
To obtain Grb4-CTAP, the Grb4 coding region was subcloned from clone 
IRALp962J117Q2 (RZPD) into pRVCTAPGw (Cellzome) by the Gateway site-
specific recombination system (Invitrogen). To generate Grb4-YFP, Grb4 SH2-YFP 
or Grb4 SH3-YFP, the Grb4, SH2 (283-380) or SH3 (1-255) coding region from clone 
IRALp962J117Q2 was cloned into pECFP-N1 (Clontech) using BamHI and XhoI 
restriction sites.  
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7.1.3.3 GRIP1 expression constructs 
 
To obtain UbiKOZ-GRIP1-CTAP for injection into oocytes, the CTAP and GRIP1 
coding regions were subcloned from pRVCTAP-GRIP1 (Cellzome) into UbiKOZ 
(based on pUC18, Francesca Diella) using XhoI (CTAP) and NotI (GRIP1) restriction 
sites. To generate GRIP1-myc, the GRIP1 coding region was subcloned from 
pRVCTAP-GRIP1 into pCDNA3.1Amyc/his using XbaI and KpnI restriction sites. 
Point-mutated GRIP1-myc was generated by site directed mutagenesis leading to 
exchange of Ser944, Thr956 or Ser944 and Thr956 to Ala. 
 
7.1.3.4 EphrinB1 interfering peptide expression construct 
 
To generate ephrinB1-313-335-EYFP, the respective ephrinB1 coding regions from 
HA-ephrinB1 (see below) were cloned into pEYFP-N1 (Clontech) using BamHI and 
HindIII restriction sites.  
 
7.1.3.5 Other expression constructs 
 
The expression construct of HA-ephrinB1 was provided by Manuel Zimmer and 
ECFP-ephrinB1-ΔC by Jenny Köhler. Expression construct encoding βPIX-Flag was 
a gift from Dongeun Park and is described (Lee et al. 2001). The expression 
constructs of EphB2-Flag is described (Dalva et al. 2000). Expression vector encoding 
HA-14-3-3 was generated using the Gateway site-specific recombination system 
(Invitrogen) to insert the PCR-amplified ORF of 14-3-3ζ (IMAGE: 2988020; RZPD) 
into the HA-tagged version of the MoMLV-based vector pZome1 (Cellzome). 
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7.1.4 Chemicals and commercial kits 
 
100x L-glutamine (Invitrogen) 
100x penicillin / streptomycin. (Invitrogen) 
30% Acrylamid/Bis 25:1 (Biorad) 
β-Mercaptoethanol (Sigma) 
BES (Sigma) 
Biorad Dc Protein Assay (Biorad) 
BSA (Sigma) 
Complete, Protease inhibitor cocktail tablets (Roche) 
Complete EDTA-free, Protease inhibitor cocktail tablets (Roche) 
Dithiothreitol (DTT) (Sigma) 
ECL Western Blot detection reagent (Amersham) 
EDTA (Sigma) 
EGTA (Sigma) 
EphB2-Fc chimera, mouse (R&D)  
Films, Kodak Biomax MS Film (Sigma) 
Foetal bovine serum (FBS) (Invitrogen) 
Gateway-specific recombination system (Invitrogen) 
Gel/Mount (Biomeda) 
Geneticin sulfate (G418) (Invitrogen) 
Glutathione-sepharose beads (Pharmacia) 
Iron-supplemented calf serum (Sigma) 
Human IgG-Fc fragment (Dianova) 
Mouse-laminin, natural (Invitrogen) 
Normal Donkey Serum (Dianova) 
Normal Goat Serum (Dianova) 
Nonidet P-40, IGEPAL CA-630 (Roche) 
OptiMEM GlutaMAX (Invitrogen) 
Optiprep (Nycomed Pharma) 
Orange G (Sigma) 
PfuUltra High-Fidelity DNA polymerase (Stratagene) 
phenylmethylsulfonyl fluoride (PMSF) (Sigma) 
Poly-D-lysine (Sigma) 
Poly-L-lysine (Sigma) 
PonceauS solution (Serva) 
Precision Plus Protein Standard (Biorad) 
Protein A Sepharose 4B (Amersham) 
Protein G Sepharose 4B (Amersham) 
Pyruvic acid (Sigma) 
QuikChange (XL-) Site-directed mutagenesis kit (Stratagene) 
TEMED (Biorad) 
Triton X-100, analytical grade (Serva) 
Trypsin/EDTA (Invitrogen) 
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7.1.5 Antibodies 
 
7.1.5.1 Primary antibodies 
 
Affinity purified anti-14-3-3  
(06-511, Upstate) 
Western-Blotting: 1:1000 
14-3-3 staining in Fig. 19, 20 
Immunoprecipitation: 4 g/IP 
Affinity purified rabbit anti-caveolin-1 
(sc-894, Santa Cruz Biotechnology) 
Western Blotting 1:1000 
caveolin staining in Fig. 19 
Rabbit serum anti-(SAM)EphB2 
(Grunwald et al. 2001) 
Western Blotting: 1:2000 
EphB2 staining in Fig. 12 
Affinity purified goat anti-ephrinB1 
(AF473, R&D) 
Western Blotting: 1:1000 
ephrinB1 staining in Fig. 12, 20  
Mouse anti-Flag  
(F3165, clone M2, Sigma) 
Western Blotting: 1:5000 
GIT1-/GIT1Y>F-Flag staining  
in Fig. 12, 13, 14, 15 
Immunoprecipitation: 1 g/IP 
Affinity purified rabbit anti-Flag 
(V10303, Biomeda) 
Immunoprecipitation: 2 g/IP  
Affinity purified goat anti-GIT1  
(sc-9657, Santa Cruz Biotechnology) 
Western Blotting: 1:500 
GIT1 staining in Fig. 12, 13, 15 
Rabbit anti-GIT1 (DU139, (Premont et 
al. 1998; Bagrodia et al. 1999) 
Western Blotting: 1:2000 
Immunocytochemistry: 1:1000 
GIT1 staining in Fig. 16 
Immunoprecipitation: 1 l/IP 
Rabbit anti-GIT2 (DU137, (Premont et 
al. 1998; Bagrodia et al. 1999) 
Western Blotting: 1:2000 
GIT2 staining in Fig. 12 
Mouse anti-GFP  
(8371-2, clone JL-8, Clontech) 
Western Blotting: 1:5000 
Grb4(SH2/SH3)-GFP staining  
in Fig. 13, 14, 15 
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Affinity purified rabbit anti-GFP  
(RDI-GRNFB4abr, RDI) 
Western Blotting: 1:3000 
Grb4(SH2/SH3)-GFP staining in Fig. 13d 
Immunoprecipitation: 1 g/IP 
Affinity purified rabbit anti-Grb4  
(07-100, Upstate) 
Western Blotting: 1:1000 
Grb4 staining in Fig. 11, 12 
Immunocytochemistry: 1:200 
Mouse anti-GRIP (611318, clone 32, 
BD Transduction Lab.) 
Western Blotting: 1:5000 
GRIP staining in Fig. 19, 20, 22 
Affinity purified rabbit anti-GRIP1, CT 
(06-986, Upstate) 
Immunoprecipitation: 2 g/IP 
Affinity purified mouse anti-HA 
(1583816, clone 12CA5, Roche) 
Western Blotting: 1:1000 
HA staining in Fig. 13, 21 
Immunoprecipitation: 4 g/IP 
Affinity purified goat anti-human Fc 
(109-005-098, Dianova) 
Fc-clustering: 1:10 w/w 
TR-conjugated goat anti human Fc 
(Jackson ImmunoResearch) 
Immunocytochemistry: 7.5 g/ml 
anti-Fc staining in Fig. 16 
Mouse anti-myc (clone 9E10) agarose 
beads (A7470, Sigma) 
Immunoprecipitation: 10 l/IP 
Mouse ascities anti-myc  
(clone 9E10) 
Western Blotting: 1:1000 
GRIP1-myc staining in Fig. 21 
Rabbit serum anti-βPIX (DU248, 
(Premont et al. 1998; Bagrodia et al. 
1999) 
Western Blotting: 1:2000 
anti-βPIX staining in Fig. 14 
 
Mouse anti-PRK2 (610794, clone 22, 
BD Biosciences Pharmingen) 
Western Blotting: 1:1000 
PRK2 staining in Fig. 14 
Affinity purified mouse anti-phospho-
tyrosine (hybridoma clone 4G10) 
Western Blotting: 1:5000 
Phospho-SLD-YFP staining in Fig. 15 
Mouse anti-PSD-95  
(P-246, clone 7E3-IB8, Sigma) 
Immunocytochemistry: 1:200 
PSD-95 staining in Fig. 11 
Mouse anti-synapsin 1  
(106 021, clone 46.1, Synaptic Systems) 
Immunocytochemistry: 1:500 
synapsin 1 staining in Fig. 17 
Rabbit anti-synaptophysin 1  Western Blotting: 1:1000 
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(101002, Synaptic Systems) synaptophysin 1 staining in Fig. 11 
Affinity purified mouse anti-human 
transferrin receptor (13-6800, clone 
H68.4, Zymed Laboratories Inc.) 
Western Blotting: 1:1000 
transferrin receptor staining in Fig. 19 
Mouse anti-V5  
(R960-25, Invitrogen) 
Western Blotting: 1:5000 
SLD-V5 staining in Fig. 13 
Rabbit IgG Agarose (A-2909, Sigma) Immunoprecipitation: 20 μl/IP 
ephrinB1-Fc (473-EB, R&D) Pulldown: 10 μg/pulldown 
EphB2-Fc (467-B2, R&D) Pulldown: 10 μg/pulldown 
 
7.1.5.2 Secondary antibodies 
 
Donkey anti-mouse-Cy3, -Cy5, -Texas 
Red (715-165-151, 715-175-151, 715-
075-151, Jackson ImmunoResearch) 
Immunocytochemistry: 3.75 g/ml 
Donkey anti-rabbit-Cy3, -Cy5 (711-165-
152, 711-175-152, Jackson 
ImmunoResearch) 
Immunocytochemistry: 3.75 g/ml 
Donkey anti-goat antibody HRP 
conjugate (705-035-003, Jackson 
ImmunoResearch) 
Western Blotting: 1:3000 
Goat anti-mouse antibody HRP 
conjugate (115-055-003, Jackson 
ImmunoResearch) 
Western Blotting: 1:3000 
Goat anti-rabbit antibody HRP 
conjugate (111-035-003, Jackson 
ImmunoResearch) 
Western Blotting: 1:3000 
Peroxidase Anti-Peroxidase (PAP) 
Soluble Complex antibody produced in 
rabbit (P-1291, Sigma) 
Western Blotting: 1:3000 
PAP staining in Fig. 12 
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7.1.6 Cell lines 
 
HeLa Human cervix carcinoma 
cells 
DMEM, FCS 
HeLa ephrinB1 
(kindly provided by KS 
Erdmann, Ruhr University 
Bochum) 
Human cervix carcinoma 
cells stably expressing 
ephrinB1 constructs 
DMEM, FCS, G418 
SK-N-BE2 Human Caucasian 
neuroblastoma cells 
OptiMEM I 
GlutaMAX,  
Iron suppl. CS 
SK-N-BE2 Grb4-CTAP 
(clone ZF_C2) 
Human Caucasian 
neuroblastoma cells stably 
expressing Grb4-CTAP 
OptiMEM I 
GlutaMAX,  
Iron suppl. CS 
SK-N-BE2 GRIP1-CTAP 
(clone XB C-180) 
Human Caucasian 
neuroblastoma cells stably 
expressing GRIP1-CTAP 
OptiMEM I 
GlutaMAX,  
Iron suppl. CS 
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7.1.7 Other materials and equipment 
 
Centrifuge Varifuge 3.0R (Kendro) 
Centrifuge Centrifuge 5810 (Eppendorf) 
Rotor GSA rotor & type 3 (Sorvall) 
Table centrifuge Centrifuge 5415 D (Eppendorf) 
Mini centrifuge Quickspin Minifuges, C-1200 (International Labnet) 
Incubator shaker Unitron-Pro (Infors) 
Thermo mixer Thermomixer comfort (Eppendorf) 
Balance XT2220M-DR (Precisa) 
Fine balance XT2220A-FR (Precisa) 
Magnetic stirring bar 50 × 8 mm (Brand) 
pH Meter Inolab, pH Level 1 (WTW) 
Electrophoresis power supply EPS 601 (Amersham) 
Water purification system Milli-Q Biocel A10 (Millipore) 
PCR machine Peltier Thermal Cycler, PTC-225 (MJ Research) 
Shaker IKA Schüttler MTS 4 IKA® (Werke) 
Shaker POLYMAX 2040 (Heidolph) 
Magnetic Stirrer with heating IKAMAG®Ret IKA® (Werke) 
Hood HERAsafe (Kendro) 
Laminar air flow hood HERAguard (Kendro) 
CO2 incubator HERAcell® 240 (Kendro) 
Spectrophotometer Ultrospec 3000 (Amersham) 
Vacuum sucking system VacuSafe (Integra Biosciences) 
Sequencer ABI Prism 377 DNA sequencer (Applied Biosystems) 
Vortexer VF2 IKA® (Werke) 
Epifluorescence microscope Zeiss Axioplan (Zeiss) 
Digital camera SpotRT (Diagnostics Instruments) 
Semidry blotting apparatus (Pharmacia) 
Nitrocellulose membrane, 0.45μm pore size (Scleicher & Schuell) 
BioRad gel system (BioRad) 
Straight forceps, Biology tip Dumont #5 (11252-20, Fine Science Tools) 
Vannas-Tübingen spring scissors (15003-08, Fine Science Tools) 
Dissection stereomicroscope Stemi SV 11 (Zeiss) 
Dissection lamp KL 1500 LCD (Leica) 
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7.2 Methods 
 
7.2.1 Molecular Biology 
 
7.2.1.1 Preparation of plasmid DNA 
 
Plasmid DNA was purified from small-scale (5 ml, minipreparation) or from large-
scale (100 ml, maxipreparation) bacterial cultures. For this, single colonies of 
transformed bacteria or from a bacterial glycerol stock were picked each into 2 ml LB 
medium containing 100 µg/ml ampicillin or kanamycin and grown over day. 100ml 
LB medium containing the antibiotics were then inoculated with 1ml from this 2 ml-
culture and grown overnight (ON) at 37°C with vigorous shaking. The bacterial 
suspension was pelleted by centrifugation at 4,000 rpm for 20 min at 4°C. The pellet 
was resuspended in buffer P1 (QIAGEN). Mini- and maxipreparation of plasmid 
DNA were carried out according to the QIAGEN protocol (Qiagen Miniprep Spin kit, 
Qiagen HiSpeed Maxi Kit) using lysis of the cells and binding of the plasmid DNA to 
a special resin. After washing, elution and precipitation the plasmid DNA was 
redissolved in a suitable volume of H2O for minipreparation or endotoxin-free TE 
buffer (QIAGEN) for maxipreparation. DNA concentration was measured in a UV 
spectrometer at 260 nm. The following formula was used: dsDNA: OD × 50 × 
dilution factor = X µg/ml 
 
7.2.1.2 Enzymatic treatment of DNA 
 
Cleavage of plasmid DNA: Approximately 1 µg of DNA was cut in 50 µl of the 
appropriate NEB-buffer, 1xBSA (if required) and 2 to 5 units (U) restriction enzyme 
(NEB) for 1 to 2 h at an appropriate temperature. 
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7.2.1.2.1 Dephosphorylation of DNA fragments  
 
For dephosphorylation of DNA fragments, 1 U (1 µl) of shrimp alkaline phosphatase 
(1758250, Roche) was added to a 50 µl-restriction enzyme reaction, incubated for 60 
min at 37°C and heat-inactivated at 65°C for 15 min. Subsequently, the 
dephosphorylated DNA fragments were purified from the reaction mix (see 
purification of DNA). 
 
7.2.1.2.2 Ligating vector and insert  
 
A 10 µl reaction containing purified linearized and dephosphorylated vector and DNA 
fragments (“insert”) in equimolar ratio, 1 µl of T4 DNA ligase (M0202L, NEB) and 
ligation buffer (10× T4 DNA ligase buffer, NEB) was incubated ON at 16°C or at RT 
for 1 h, followed by 30 min at 37°C for sticky end ligations. Then, 2 µl of the ligation 
reaction were used to transform competent bacteria. 
 
7.2.1.3 Separation of DNA on agarose gels 
 
The DNA mix and approximately 1/6 of the volume of 6×loading buffer were loaded 
onto an 0.8-2% agarose gel in TAE buffer containing ethidium bromide (2218.2, 
Roth, use 1 µl per 100 ml) and run for approximate 30 to 35 min at 100-200 V. After 
electrophoresis a photograph of the gel was taken in the transilluminator on a UV light 
box and printed. In a preparative gel, the DNA band was excised from the agarose gel 
with a clean, sharp scalpel and purified (see purification of DNA). 
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7.2.1.4 Purification of DNA 
 
7.2.1.4.1 From agarose gel  
 
Following extraction, purification of DNA fragments from agarose gels was carried 
out using the QIAquick Gel Extraction Kit (28704, QIAGEN) as recommended by the 
manufacturer. The DNA was eluted in 30 µl H2O. 
 
7.2.1.4.2 From enzymatic reactions  
 
To clean-up DNA fragments from salts, enzymes, unincorporated nucleotides, the 
QIAquick Nucleotide Removal Kit (28104, QIAGEN) was used according to the 
protocol of QIAGEN. The DNA was eluted in 30 µl H2O. 
 
7.2.1.5 Transformation of competent E. coli by electroporation 
 
50 µl of electro competent bacteria were gently thawed on ice, mixed with 1-2 µl of 
the ligation product. Sterile 0.2 cm (green) cuvettes were placed on ice. Gene pulser 
apparatus (BioRad) was set at 25 µF and to 2.5 kV; the pulse controller to 200 W. The 
mixture of bacteria and DNA was transferred to a cold electroporation cuvette and 
knocked down to the bottom of the cuvette. The cuvette was placed in the chamber 
slide, pushed into the chamber and pulsed once at the above settings. 1 ml LB medium 
was immediately added to the cuvette. The cells were resuspended, transferred to a 
reaction tube and incubated at 37°C for 60 min with shaking at 225-250 rpm. The 
bacteria were then plated on LB agar plates containing the appropriate antibiotic for 
the plasmid vector and incubated at 37°C ON. 
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7.2.1.6 Mutagenesis 
 
All mutagenesis (see plasmids) were performed using the QuikChange Site-Directed 
Mutagenesis Kit according to the protocol of Stratagene (200519). All desired 
mutations were verified by sequencing procedure (Ms. Thyrlas, MPI of 
Neurobiology). 
 
7.2.1.7 Extraction of genomic DNA and genotyping using PCR 
 
7.2.1.7.1 DNA preparation  
 
DNA was prepared from mouse tail by treatment with 100 μg/ml Proteinase K in tail 
lysis buffer. 40 µl of tail lysis buffer including Proteinase K was added to each 
approximate 2 mm mouse tail, which was placed at 56°C for 2 h. Proteinase K was 
then heat-inactivated for 5-10 min at 95°C. Before PCR, the genomic DNA prep was 
diluted with 900 µl H2O. 
 
7.2.1.7.2 PCR Ubi-GRIP  
 
1 µl of DNA per 50 µl PCR reaction was used for PCR amplification to check the 
DNA for the presence of the transgene. 
 
PCR master mix: 
5 µl 10×PCR buffer (Roche) 
0.5 µl 25 mM dNTPs 
0.5 µl 100 pmol/µl Sense-primer (GRIP1.9_Seq) 
0.5 µl 100 pmol/µl Antisense-primer (TAPgeno2_AS) 
1 µl Taq DNA polymerase (M0267L, NEB)  
1 µl genomic DNA 
to 50 µl add distilled water 
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Segment Cycles Temperature Time 
1 1 95°C 2 min 
2 35 95°C 1 min 
  60°C 1 min 
  72°C 1 min 
3 1 72°C 10 min 
 
The PCR product was mixed with 6×loading buffer, loaded on a 1.5% agarose gel and 
then electrophoresed for approximately 30 min at 200 V.  
 
7.2.1.7.3 PCR GRIP1-KO  
 
1 µl of DNA per 55 µl PCR reaction was used for PCR amplification to check the 
DNA for the presence of the KO allele. 
 
PCR master mix: 
5.5 µl 10×PCR buffer (Roche) 
0.5 µl 25 mM dNTPs 
0.25 µl 100 pmol/µl RHKT83 
0.25 µl 100 pmol/µl RHKT63 
0.25 µl 100pmol/µl RHKT55 
1 µl Taq DNA polymerase (M0267L, NEB)  
1 µl genomic DNA 
to 55 µl add distilled water 
 
Segment Cycles Temperature Time 
1 1 95°C 2 min 
2 35 95°C 1 min 
  60°C 1 min 
  72°C 20 sec 
3 1 72°C 5 min 
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The PCR product was mixed with 6×loading buffer, loaded on a 1.5% agarose gel and 
then electrophoresed for approximately 30 min at 200 V.  
 
7.2.1.8 Generation of transgenic mice 
 
Vector sequences, particularly prokaryotic promoter and origin (ori) sequences impair 
the expression of the transgene. Therefore, single cutting restrictions sites should 
flank the final DNA fragment and this should be taken into consideration during 
design of the construct. 
 
7.2.1.8.1 Plasmid digestion  
 
Plasmid UbiKOZ-GRIP1-CTAP (see plasmids) was purified for pronuclear injection 
from large-scale bacterial cultures using the HiSpeed Plasmid Maxi Kit without EtOH 
(12663, QIAGEN). About 110 µg of the plasmid were digested with 70 U of the 
restriction enzyme XmaI (NEB) and 220 U of NdeI (NEB) overnight. Next day, 
another 70 U of the restriction enzyme XmaI and 220 U of NdeI were added and again 
incubated overnight. 500 ng of the reaction mix was loaded and run on an agarose gel 
to check if digestion was complete. 
 
7.2.1.8.2 Pronuclear injection  
 
The pronuclear injection was carried out by the transgenic mice service of the EMBL, 
Heidelberg (Kristine Vintersten).  
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7.2.2 Cell Culture 
 
7.2.2.1 Primary culture of hippocampal neurons 
 
Before preparation, coverslips were pre-coated with 1mg/ml Poly-D-lysine in borate 
buffer for at least 4 h at 37°C. Coverslips in 24-well plates were washed twice with 
sterile water and dried in a sterile hood. After coating overnight at 37°C with 5 µg/ml 
mouse laminin in PBS, coverslips were washed twice with PBS and then replaced by 
Neurobasal-B27 medium. Media were left to equilibrate for at least one hour in the 
incubator with 5% CO2 atmosphere. Hippocampal neurons were taken from pregnant 
Wistar rats (MpiChbb:Thom, animal house, MPI of Neurobiology) at E18.5. Pregnant 
rats were deeply anesthetized using diethyl ether. After cervical dislocation, embryos 
were obtained and kept in ice-cold dissection medium. The preparation was then 
continued under an open sterile hood. Embryo heads were cut off and the scull opened 
to take out the brain. Embryonic brains were placed in fresh dissection medium and 
dissected under a stereomicroscope. Brain cortices were removed from the midbrain 
and brainstem and the meninges were pulled off. The striatum was cut out. The 
hippocampus was separated from the cortex and placed in fresh 15 ml dissection 
medium on ice. After removing the medium, hippocampi were incubated in 1.5 ml 
0.25%Trypsin/1mM EDTA-HBSS-solution (25200-056, Invitrogen) for 20 min at 
37°C. After carefully removing Trypsin/EDTA-HBSS-solution, the digestion reaction 
was stopped and the hippocampi were washed three times with 3 ml DMEM 10% 
FBS. Then the tissue was triturated approximately 20 times using a fire-polished glass 
pasteur pipette until the suspension was homogenous. Subsequently, the cell 
suspension was centrifuged for 5 min at 80 g to remove debris and the pellet 
resuspended in 2 ml Neurobasal-B27 medium. Cells were counted in a hemacytometer 
and plated on coated glass coverslips in a 24-well plate at a density of 620 cells/mm2. 
Cells were incubated for 11-21 days in vitro (DIV) at 37°C in a humidified incubator 
with an atmosphere of 5% CO2. After 7 or 12 DIV the hippocampal cultures were 
transfected using the Ca-phosphate-DNA precipitation procedure. 
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7.2.2.2 Transfection of cells 
 
HeLa cells were transfected following a conventional Ca-phosphate-DNA 
precipitation procedure (Sambrook et al. 1989). For calcium phosphate transfection of 
hippocampal neurons on coverslips, all solutions were warmed up to room 
temperature. The CaCl2-DNA-BBS mixture was added drop wise to 0.9 ml medium in 
a polystyrene-tube (Falcon) while vortexing. After collecting the remaining medium 
from 4 wells, 250 μl of the transfection solution was immediately added to each well. 
The collected medium was filter-sterilized and kept in the incubator. Cells were 
incubated at 37°C in a humidified incubator with an atmosphere of 5% CO2 for the 
desired transfection time (1-3 h). Afterwards, the transfection medium was removed 
and cultures were washed with prewarmed HBSS (14025-050, Invitrogen) twice and 
kept for 10 min each time in a 37°C incubator (no CO2 atmosphere). Then the “old” 
prewarmed culture medium was readded. 
 
7.2.2.3 Stimulation of cells with Eph receptors or ephrin ligands 
 
All cell types were stimulated with EphB2-Fc or Fc (Biochemistry: 1 µg/ml, 
Immunocytochemistry: 4 µg/ml), which had been pre-clustered for 1 h at room 
temperature using 1/10 (w/w) goat anti-human IgG (Jackson Immunoresearch). 
Before stimulation, all cell types except hippocampal neurons were starved for 24 h in 
medium containing 0% serum.  
 
7.2.3 Biochemistry 
 
7.2.3.1 Tandem affinity purification and mass spectrometry 
 
Retroviral transduction vectors were generated by cloning open reading frames, 
amplified by polymerase chain reaction, into a Moloney-based vector with the 
Gateway site-specific recombination system to obtain C-terminal TAP fusions of 
Grb4 and GRIP1. Virus stocks were generated in a HEK293 Gag–Pol packaging cell 
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line. SK-N-BE2 cells were infected and complexes were purified by using a modified 
TAP protocol (Gavin et al. 2002). Cells were grown in Optimem Glutamax 
(Invitrogen) medium with 10% iron supplemented FBS (Sigma). Eighty 15 cm-dishes 
of SK-N-BE2 Grb4-CTAP or SK-N-BE2 GRIP1-CTAP cells were harvested by 
mechanical detachment, washed with excess PBS on ice and lysed in 10 ml lysis 
buffer each using a Dounce homogenizer (30 times). Afterwards, lysates were 
incubated spinning on a wheel for 30 min at 4°C and then centrifuged for 10 min 
(13,000 rpm, 4°C, SS34 rotor). The supernatant was added on 200 μl rabbit IgG 
agarose beads (Roche) in a 15 ml-Falcon tube and incubated for 2h at 4°C. Beads 
were saved by centrifugation for 1 min (1,300 rpm, 4°C, Varifuge 3.0R), transferred 
into a small column (0.8 ml Mobicol M1002, MoBiTec) and washed with 10 ml lysis 
buffer followed by a wash with 5 ml TEV cleavage buffer. Beads were resuspended in 
150 μl TEV cleavage buffer and incubated upon addition of 4 μl TEV protease 
(recombinant, 10127-017, Invitrogen) for 3 h at 16°C in a thermoshaker (900 rpm). 
The TEV eluate was directly applied on calmodulin affinity resin (214303-52, 
Stratagene) in another column, mixed with 200 μl CBP binding buffer and incubated 
for 1 h at 4°C. Calmodulin beads were washed with 5 ml CBP washing buffer and the 
protein complexes eluted with 600 μl CBP elution buffer for 5 min at 37°C. Both the 
calmodulin beads after elution and the lyophilized protein samples were boiled for 5 
min with 50 μl 4x sample buffer (containing 20 mM DTT) and separated by NuPAGE 
4-12% Bis-Tris–PAGE (NP0321BOX, Invitrogen). Complete gel lanes were 
systematically cut into slices and proteins were digested in-gel with trypsin as 
described (Shevchenko et al. 1996). Protein identification was performed by LC–
MS/MS at Cellzome AG (Heidelberg) and MS data were searched against an in-house 
curated version of the International Protein Index (IPI), maintained at the EBI 
(Hinxton, UK). Results of database searches were read into a database system for 
further bioinformatics analysis. 
 
7.2.3.2 Cell lysis, immunoprecipitation, EphB2-Fc-pulldown experiments 
 
Transiently transfected HeLa cells were washed twice with ice-cold PBS and lysed in 
lysis buffer on ice. After scraping off and collecting the cells from the dish, the cell 
lysate was centrifuged at 10,000 g for 15 min at 4°C to remove insoluble material 
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(nuclei, cytoskeletal components and insoluble membranes). The supernatant was 
placed in a fresh Eppendorf tube and directly loaded onto a SDS-Polyacrylamide gel 
(SDS-PAGE) or purified further (see below). Before loading on a gel, samples were 
boiled in 6×sample buffer for 7 min to denature the proteins.  
For immunoprecipitation, 2-4 µg of the antibody against the protein of interest was 
prebound to protein A sepharose (for rabbit polyclonal antibodies) or protein G 
sepharose (for mouse monoclonal and goat polyclonal antibodies) for 30 min at RT. 
The total lysate was added and incubated for 2 hours on a rotating wheel at 4°C. 
Subsequently, the mixture was spun down at 4,000 g for 2 min at 4°C. The 
supernatant was discarded and the beads were washed three times with lysis buffer to 
remove traces of unbound proteins. 25 µl of 2×sample buffer was added to the beads 
and the mix was then boiled for 5 min. The entire sample was loaded on a SDS-PA 
gel under reducing conditions and further processed. 
EphB2-Fc precipitation from brain tissue or immunoprecipitation of ephrinB1-
HA/Grb4-YFP complexes from HeLa cells were performed following the protocol 
described (Cowan and Henkemeyer 2001). Briefly, 10 µg of EphB2-Fc (R&D 
Systems) or 4 µg of anti-HA (Roche) were coupled to protein G sepharose beads 
(Amersham) and incubated 2 h at 4°C with the lysates (1 mg/ml) prepared in PLC 
lysis buffer containing 1% NP-40. Bound proteins were then washed three times in 
HNTG for the EphB2-Fc pulldowns or three times in PLC lysis buffer followed by 
two washes in HNTG for HA-immunoprecipitations. Samples were then boiled 7 min 
in sample buffer, resolved by SDS-PAGE, transferred to nitrocellulose and 
immunoblotted with the indicated antibodies. 
 
7.2.3.3 Immunoblotting 
 
Protein samples derived from the procedures described above were separated by SDS-
PAGE and transferred to nitrocellulose or PVDF membranes by semi-dry blotting (1 
mA per cm2 for 1 to 1.5 h). Membranes were blocked at least for 30 min at RT or 
overnight at 4°C in blocking solution and then incubated for 1 h at RT or overnight at 
4°C with a primary antibody diluted in blocking solution. Subsequently, membranes 
were washed three times for 10 min in PBST at RT. Secondary antibodies linked to 
horseradish peroxidase (HRP) diluted in blocking solution were used to specifically 
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recognize the primary antibody. After incubation for 1 h at RT, membranes were 
washed three times for 10 min in PBST. To visualize signals, membranes were 
incubated with ECL solution for 1 min at RT and exposed to films. For reprobing, 
membranes were stripped with stripping buffer. 
 
7.2.3.4 Purification of membranes and rafts from adult mice 
 
For the analysis of detergent-insoluble complexes in flotation gradients, a membrane 
fraction was prepared at 4ºC as follows. Two brains from adult mice were 
homogenized in a Dounce homogenizer in 3 ml of ice-cold homogenization buffer 
TNE. The extract was passed ten times through a 22G needle, ten times through 25G 
needle and centrifuged for 15 min (13,000 g, 4ºC). The pellet was re-extracted with 1 
ml of TNE buffer using a 25G or 27G needle and centrifuged again for 15 min 
(13,000 g, 4°C). The supernatants of both centrifugations were adjusted to 40% 
Optiprep and overlaid in a SW40 centrifuge tube with 7 ml of 30% and 3 ml of 5% 
Optiprep in TNE buffer. After centrifugation for 4 h (24,000 rpm, 4ºC; SW40 rotor), 
the floated membranes were collected in 600 µl from the 5%/30% interface. 
Membranes were adjusted to 0.3% Triton X-100 following extraction for 30 min on a 
wheel at 4°C. The extracted membranes were adjusted to 40% of Optiprep and 
overlaid in a SW60 centrifuge tube with 2.5 ml 35% Optiprep and 400 µl of 5% 
Optiprep in TNE buffer. After centrifugation for 4 h (40,000 rpm, 4ºC; SW60 rotor) 
seven fractions were collected from the top. 
 
7.2.3.5 Postsynaptic density fractionation 
 
Postsynaptic densities were prepared as described by Cho (Cho et al. 1992). In brief, 
hippocampi of 12 wt C57/BL-6 adult male mice were homogenized in a dounce glass 
Teflon homogenizer in 12 ml solution A and centrifuged at 3,000 g for 10 min at 4ºC. 
Pellets were re-extracted with 5 ml solution A, centrifuged at 1,000 g for 10 min at 
4ºC, supernatants combined with the ones from the previous centrifugation and 
centrifuged at 10,000 g for 10 min at 4ºC. Pellets were resuspended in 5 ml solution 
B, overlaid on a 1.2 M/1.0 M/0.85 M sucrose gradient and ultracentrifuged at 25,500 
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g for 2 h at 4ºC. A synaptic membrane fraction was extracted at the interface of 1.2 
M/1.0 M sucrose layers and a control non-synaptic fraction was extracted between the 
top (0.32 M) and the 0.85 M sucrose layer. The synaptosome fraction was diluted to 9 
ml in solution B, 9 ml of solution C was added followed by a 15 min incubation on 
ice. The solution was divided into 6 samples and pelleted at 22,300 g for 20 min at 
4ºC. One pellet was resuspended in 100 μl solution D (PSD fraction 1), the remaining 
five pellets in 5 ml solution B. 2 ml of this solution were mixed with 2 ml solution C, 
incubated on ice for 15 min and centrifuged at 50,100 g for 60 min at 4ºC. The 
resulting pellet was resuspended in 100 μl solution D, 0.3% SDS (PSD fraction 2). 
The remaining 3 ml were mixed with 3 ml sol E, incubated on ice for 15 min, 
centrifuged at 50,100 g for 60 min and the pellet resuspended in 100 μl solution D 
(PSD fraction 3). For a description of solutions used, please refer to the Materials 
section. 
 
7.2.3.6 Immunocytochemistry 
 
7.2.3.6.1 Immunostaining of cells 
 
For normal immunocytochemistry of total protein distribution, neurons grown on 
coverslips were fixed with 4% PFA, 4% sucrose in PBS for 13 min at 4°C, washed 
once with PBS, then incubated with 50mM NH4Cl in PBS for 10 min at 4°C and 
washed again before permeabilization for 5 min with ice-cold 0.1% Triton X-100 in 
PBS. After washing, coverslips were blocked for about 30 min at RT or overnight at 
4°C with 2% bovine albumin (A-3294, Sigma) and 4% serum in PBS. After blocking, 
coverslips were transferred into a dark moist chamber, face up. Primary antibodies for 
total stainings were incubated for at least 60 min at RT in 50 µl blocking solution. 
After 3 washing steps with PBS for 5 min, secondary antibodies, previously diluted in 
50 µl of blocking solution, were applied for 30 min at RT in the dark. After washing, 
samples were mounted in Gel/Mount media and dried at RT. Images were acquired 
using an epifluorescence microscope (Zeiss) equipped with a digital camera (SpotRT, 
Diagnostic Instruments) and the MetaMorph software (Visitron Systems). 
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7.2.3.6.2  Image analysis and quantification 
 
Images were acquired using a digital camera (SpotRT; Diagnostic Instruments, 
Sterling Heights, MI) attached to an epifluorescence microscope (Zeiss, Göttingen, 
Germany) equipped with a 63X objective (Plan-Apochromat; Zeiss, Göttingen, 
Germany). All quantitative measurements were performed using MetaMorph 
software. Statistical analysis was performed using Microsoft Excel. Groups of 
protrusions were compared using t-test. Neurons expressing high levels of the 
constructs were chosen for quantification as follows. Approximately 100 dendrites 
from independent transfections were randomly selected for each construct to quantify 
number of protrusions in proximal 50 µm sections of dendrites. Length of protrusions 
was determined by measuring the distance between the tip and the base (n>500 
protrusions). 
 
7.2.4 Mouse work 
 
Transgenic mice were crossed in a C57/Black6 (C57BL/6NCrlMpi, animal house, 
MPI of Neurobiology) genetic background. For experiments with adult mice, mice 
were separated from their parents at the age of about three weeks, males and females 
were housed separately. Tail biopsies were taken and mice were ear tagged using six-
digit number eartag from the Nationalband & Tag company. For all experiments a 
heterozygous transgenic male was crossed with wild type females and the mice of the 
same litter were compared. 
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